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Abstract
Tissue engineering is a field aiming to replace damaged tissue while reduc-
ing the great need of organ donors the world is facing today. Alginates are
linear co-polymers consisting of the two monosaccharides β-d-mannuronic
acid (M), and its 5-epimer α-l-guluronic acid (G). They can form hydrogels,
and are candidates for use in tissue engineering scaffolds. Alginate is readily
available at a low cost, and its hydrogels meet requirements of scaffolds such
as mechanical strength and good biocompatibility, but lack the ability to
interact with cells and proteins. The aims of this study was to investigate
properties of alginate/alginate-sulfate mixtures for tissue engineering appli-
cations. This included the gel strength, osmotic stability in physiological
solutions, distribution in gels, and interactions with the growth factor FGF.
Mixing of formamide and HClSO3 with alginate LF200S yielded, as shown
by ICP-MS, sulfated alginate with degrees of sulfation (DS) depending on
the concentration of HClSO3, volume of reaction mixture and the solubility
of the alginate. Use of SEC-MALLS revealed some depolymerization of the
alginate during the sulfation process, and showed that sulfation of alginate
increases its susceptibility to acid hydrolysis at 95◦C and pH 5.6. Use of
alginate/alginate-sulfate mixtures was shown by swelling studies to have a
higher osmotic stability in a physiological solution than pure alginate-sulfate
beads when comparing total sulfate content. Increased content of sulfate in
the beads generally led to decreased stability. Some hybrid beads containing
low proportions of alginate-sulfate showed a higher stability than beads made
from pure alginate. Increased proportions of alginate-sulfate in mixtures led
to decreasing gel strengths, as shown by a longitudinal compression test. The
Young’s modulus of the gels ranged from 310 kPa (135 kPa when corrected
for syneresis) to 26 kPa (16 kPa), placing them in the same range as several
tissues. Interactions between FGF and alginate-sulfate in solution increased
in strength for an increasing DS or a higher proportion of alginate-sulfate
in mixtures. Gel disks made from mixtures all released FGF gradually into
the surrounding medium. Gels containing alginate-sulfate still retained some
FGF after 12 days, in contrast to the pure alginate gels. The mechanical
strength, ability to interact with FGF, osmotic stability and tunable distri-
bution make alginate/alginate-sulfate mixtures possible candidates for tissue
engineering applications.
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Sammendrag
Feltet ”tissue engineering” tar sikte p˚a a˚ erstatte skadd vev, og samtidig re-
dusere det store behovet for organdonorer verden st˚ar overfor i dag. Alginater
er lineære polymerer best˚aende av monosakkaridene β-d-mannuronsyre (M)
og dens 5-epimer α-l-guluronsyre (G). Alginater kan danne hydrogeler, og
er kandidater for bruk som stillasverk i ”tissue engineering”. Alginat er lett
tilgjengelig til en lav pris, med hydrogeler som innfrir stillasverk-egenskaper
som mekanisk styrke og god biokompabilitet, men mangler evnen til samhan-
dling med proteiner og celler. Ma˚let for denne studien var a˚ undersøke egen-
skaper ved alginat/alginatsulfat-blandinger for bruk innen ”tissue engineer-
ing”. Dette omfatter gelstyrke, osmotisk stabilitet i fysiologiske løsninger,
fordeling i geler, og interaksjon med vekstfaktoren FGF. Alginat LF200S ble,
som bekreftet av ICP-MS, sulfatert ved bruk av formamid og HClSO3. Den
resulterende sulfateringsgraden var avhengig av konsentrasjon av HClSO3,
reaksjonsvolum og alginatets løselighet. Bruk av SEC-MALLS viste at sulfa-
teringsprosesssen førte til en delvis depolymerisering av alginatet. Videre ble
det vist at sulfatering av alginatet medførte en høyere s˚arbarhet for syre-
hydrolyse ved 95◦C og pH 5.6. Bruk av alginat/alginatsulfat-blandinger
hadde, m˚alt ved bruk av svellestudier, høyere osmotisk stabilitet i en fy-
siologisk løsning enn rene alginatsulfat-kuler ved sammenlikning av totalt
sulfatinnhold. Økt innhold av sulfat i kulene gav generelt lavere stabilitet,
skjønt noen hybridgeler med lavt innhold av alginatsulfat viste en høyere
stabilitet enn kuler laget av rent alginat. En lavere gelstyrke ble, ved bruk
av en kompresjonstest, vist ved økt innhold av alginatsulfat i gelene. Youngs
modulus for gelene strakte seg fra 310 kPa (135 kPa ved korreksjon for
synerese) til 26 kPa (16 kPa), hvilket plasserer dem i samme omr˚ade som
flere vevstyper. Interaksjon mellom FGF og alginatsulfat i løsning økte
i omfang ved økende sulfateringsgrad eller for økende andel alginatsulfat i
blandinger. Gelskiver laget av blandinger gav alle en gradvis frigjøring av
FGF til omkringliggende medium. Etter 12 dager var det fortsatt noe FGF
tilstede i gelskiver som inneholdt alginat-sulfat, i motsetning til i de rene
alginatskivene. Den mekaniske styrken, evnen til a˚ binde til FGF, den os-
motiske stabiliteten og justerbare fordelingen gjør blandinger av alginat og
alginatsulfat til mulige kandidater for bruk innen ”tissue engineering”.
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Symbols and Abbreviations
dn
dc
The specific refractive increment
Dav Average diameter
% S The weight % of sulfur in the alginate sample
A2 The second virial coefficient
aFGF Acidic FGF
AP Alkaline Phosphatase
APA Alginate-PLL-Alginate
ATTP Activated Partial Thrombosis Time
bFGF Basic FGF
BSA Bovine Serum Albumin
DS Degree of sulfation
E The Young’s modulus
ECMs Extracellular Matrices
EDC N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochlo-
ride
EDTA Ethylenediaminetetraacetic acid
FGG The fraction of G-monosaccharides in the polysaccharide
followed by a G-residue in the polymer chain
vii
FG The fraction of G-monomers in an alginate polymer chain
FCS Fetal calf serum
FGFRs FGF Receptors
FGFs Fibroblast growth factors
G α-l-guluronic acid
GAG Glycosaminoglycan
GDL d-glucono-δ-lactone
GlcN d-glucosamine
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HR-ICP-MS High-resoultion inductively coupled plasma mass spectrom-
etry
HRP Horseradish Peroxidase
LSCM Laser Scanning Confocal Microscopy
M β-d-mannuronic acid
MES 2-(N-morpholino)ethanesulfonic acid
MQ-water Filtrated and deionized water with a resistivity of 18.2MΩ×
cm at 25oC
PBS Phosphate Buffered Saline
PLL Poly-l-Lysine
PMT Photomultiplier Tube
ppm Parts per million
ppt Parts per trillion
RGD Arginine glycine aspartic acid
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SEC-MALLS Size exclusion chromatography coupled with multiangle laser
light scattering
Sulfo-NHS N-Hydroxysulfosuccinimide sodium salt
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1. Introduction
1.1 Alginate
1.1.1 Alginate Chemistry and Structure
Alginates are linear co-biopolymers consisting of the two monosaccharides
β-d-mannuronic acid (M), and its 5-epimer α-l-guluronic acid (G), coupled
by 1,4-glycosidic bonds (Nelson and Cretcher, 1930; Fischer and Do¨rfel, 1955;
Haug et al., 1974). The structure of the two monosaccharides are shown in
Figure 1.1.1.
Figure 1.1.1: Adapted from Gombotz et. al (Gombotz and Wee, 2012a). The
structure of β-d-mannuronic acid (M) and α-l-guluronic acid (G).
The distribution of M and G along the polysaccharide chain is non-random,
and long stretches consisting of only one of the residues are found in the
polysaccharides (Haug et al., 1966, 1967a). These homopolymeric stretches
are called G- blocks and M- blocks, depending on which monosaccharide is
present, while the alternating sequences in between are called MG- blocks
1
(Haug et al., 1967b). The natural synthesis of alginates begins with poly-
mannuronic acid, followed by conversion of some monosaccharides to α-l-
guluronic acid residues by mannuronan C5-epimerases. (Smidsrød and Moe,
2008). Several different epimerases exist, giving different block structures
depending on the specific epimerase (Strand et al., 2003b). A selection of
different epimerases have been isolated and purified, which allows for spe-
cific tailoring of the final alginate structure in laboratories (Strand et al.,
2003b). Upon epimerization, the α-l-guluronic acid changes its ring con-
formation from the 4C1 ring conformation of β-d-mannuronic acid to a 1C4
ring conformation, leaving the hydroxyl groups at C1, C3 and C4 in axial
positions, while the carboxyl group at C6 and the hydroxyl group at C2 are
in an equatorial position (Draget et al., 1997; Smidsrød and Moe, 2008). As
the glycosidic linkages are all between C1 and C4, the conformational change
alters the geometry of these linkages, so they can be either di-equatorial (eq-
eq), for an M-M linkage, di-axial (ax-ax), for a G-G linkage, or eq-ax /ax-eq,
for an M-G/G-M linkage (Draget et al., 1997; Smidsrød and Moe, 2008). The
conformation of the G monosaccharides leads to a cavity formation between
two neighbouring G -residues, as shown in Figure 1.1.2 (Draget et al., 1997).
Figure 1.1.2: Figure from (Draget et al., 1997) The conformation of β-d-
mannuronic and α-l-guluronic acid residues in an alginate chain, showing
how neighbouring G-residues form a cavity between them because of their
di-axial linkage.
The physical properties of alginates, such as viscosity, strength of gels and
susceptibility to hydrolysis, are determined by the proportion between the
two monosaccharide residues, and by the sequences of these, with a great
variability between different alginate sources (Haug et al., 1967b). All algi-
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nates are susceptible to thermal depolymerization, and the rate of thermal
depolymerizaton has been shown to increase as the pH of the solution de-
creases, and causes a random depolymerizaton of the polymer (Holme et al.,
2008; Smidsrød and Moe, 2008). The MG- blocks are more susceptible to
acid hydrolysis than the homopolymeric G- and M-blocks (Haug et al., 1966).
Acid hydrolysis of the polysaccharides dextran and dextran sulfate showed
that for pH values above 1, the hydrolysis rate was higher for the sulfated
sample, which Smidsrød et al. concluded was probably due to a higher pro-
ton concentration around the negatively charged polysaccharide than in the
bulk solution (Smidsrød et al., 1966). For random depolymerizaton of a lin-
ear polymer with n monosaccharides, and n-1 ≈ n linkages, one can assume
a pseudo first order reaction with respect to n, as shown in Equation 1.1.1
(Christensen, 2013).
−dn
dt
= kn (1.1.1)
Assuming long chains, and thus large molecular weights, Equation 1.1.2 can
be used to determine the rate constant graphically when molecular weights
are known, as a plot of 1
Mw
against time gives a straight line with slope k2M0
and interception at 1
Mw,0
(Christensen, 2013).
1
Mw
= 1
Mw,0
+ k2M0
t (1.1.2)
where Mw is the weight average molecular weight of the sample at a time
t, Mw,0 is the initial weight average molecular weight of the polymers in the
sample, M0 is the molecular weight of each monosaccharide in the polymer
chain, and k is the pseudo first order rate constant.
The pKa values of the individual monosaccharides are found to be 3.65 for
the G monomers, and 3.38 for the M monomers in 0.1 M NaCl, and an abrupt
decrease in pH will cause precipitation of alginate from the solution (Haug,
1964; Draget et al., 1994).
Alginate acts as a structural element in brown algae such as Laminaria Hy-
perborea or Ascophyllum nodusum and is also produced extracellularly by
some bacteria such as Azotobacter vinelandii, Azotobacter choococcum and
several Pseudomonas species (Haug et al., 1967b; Linker and Jones, 1966;
Sherbrock-Cox et al., 1984). Bacterial alginates are usually O-acetylated on
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the 2- or 3- position, or both, of the M-residues, while the alginates isolated
from algae are without these modifications (Linker and Jones, 1966; Gacesa,
1998).
Alginates are abundant in the nature and commercially available at low cost,
making it an attractive material for use in the industry (Draget et al., 1989).
Alginates from seaweeds are used commercially as stabilisers, emulsifiers and
gelling agents in the food industry, in cosmetics, in textile industry and for
pharmaceutical applications (Sherbrock-Cox et al., 1984; Sandford et al.,
1984; Augst et al., 2006).
1.1.2 Alginate Gelling Properties
Most alkaline earth metals can cause gel formation in contact with alginate
solutions (Haug and Smidsrød, 1965). The most common ions used for al-
ginate gelation are Ba2+, Ca2+ and Sr2+, where Ba2+ is the ion binding
strongest to alginate, and Ca2+ is the one with the weakest binding of these
three (Haug and Smidsrød, 1965). The differences between binding strength
for different ions is most notable for alginates with a high content of G-
residues (Smidsrød, 1974). In addition to gelation with divalent ions, direct
addition of d-glucono-δ-lactone (GDL) to sodium alginate can also produce
gels, called alginic acid gels (Draget et al., 1994).
One explanation of the gelation process of alginate is the ”egg-box” model,
proposed by Grant et. al in 1973, which suggests that cavities formed be-
tween neighbouring G-residues offers binding places for divalent cations with
a charge dispersion on the polymer chain optimal for ionic interaction, and a
physical room fitting the size of the ions (Grant et al., 1973). An illustration
of the binding of ions in the G-block cavities is shown in Figure 1.1.3.
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Figure 1.1.3: Adapted from Grant et. al (Grant et al., 1973). The aggregation
of several alginate chains by association to divalent cations, according to the
”egg-box model”. Divalent cations, such as Ca2+, interact with the negative
charges on the alginate chain, and the G-blocks accommodate close binding
between cations and polysaccharide.
Two different approaches are used to obtain calcium-alginate gels, where the
application of the gel determines which approach is the most suitable (Draget
et al., 1993). The diffusion method is based upon letting calcium ions diffuse
into the alginate solution from an external reservoir to achieve gelation. Us-
ing this method, the gels show an inhomogeneous alginate distribution, with
a gradual decrease in concentration towards the center of the gel. This effect
becomes even more prominent when using a high alginate concentration or
alginate of low molecular weight (Skj˚ak-Bræk et al., 1989). Microcapsules
show much less inhomogeneity if they are gelled in the presence of non-gelling
ions, or after washing with saline (Strand et al., 2003a).
While external gelation is the preferred method in alginate bead immobiliza-
tion techniques, the other method, internal gelation, can be used to obtain
a more homogenous gel when this is desirable (Smidsrød and Skj˚ak-Bræk,
1990; Draget et al., 1989). In internal gelation, use of complexed calcium or
calcium-salts of a low solubility mixed into the solution, such as CaCO3, to-
gether with the slowly hydrolysing acid GDL, allows for a slow and controlled
release of calcium into the alginate solution, causing gelation (Draget et al.,
1990; Skj˚ak-Bræk et al., 1986). Internal gelation using these two chemicals
in the alginate leads to the formation of homogeneous gels over a wide pH
range, leaving the non-toxic by-products CO2 and d-gluconic acid (Draget
et al., 1989). For internal gelation inhomogeneous gels are more probable for
less viscous polymer solutions, where carbonate sedimentation occurs during
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the gelation process (Draget et al., 1990).
Ca-alginate gels have shown some syneresis in previous experiments, a state
where water is released from the hydrogel, thus leading to an increase in
the alginate concentration of the gel (Smidsrød et al., 1972; Mørch, 2008).
The syneresis is greater for gels with many and long MG-blocks, high Ca2+
concentration and a higher molecular weight (Martinsen et al., 1989; Mørch,
2008). A high concentration of CaCO3 during internal gelation can also
contribute to an increase in the syneresis of the gels (Draget et al., 1990).
1.1.3 Sulfated Alginate as a Heparin-Analogue
Functionalization of alginate is relatively easy, with its free hydroxyl and car-
boxyl groups along the backbone of the polysaccharide (Yang et al., 2011).
Modifications of alginate by researcher groups include oxidation, reductive
amination, esterification, grafting methods, amidation and sulfation (Boon-
theekul et al., 2005; Andresen et al., 1977; Rastello De Boisseson et al., 2004;
Polyak et al., 2004; Ronghua et al., 2003).
The sulfation of alginate makes its structure more similar to that of heparin,
a linear acidic polysaccharide belonging to the glycosaminoglycan (GAG)
family (Zhao et al., 2007; Shriver et al., 2012). The heparin chain con-
sists of 1 → 4 linked pyranosyluronic acid (uronic acid) and 2-amino- 2-
deoxyglucopyranose (d-glucosamine, GlcN) repeating units (Casu, 1985).
While there is at least seven different disaccharide units present in heparin,
the most common disaccharide unit is a 2-O-sulfonated l-iduronic acid 1 →
4 linked to a 6-O, N-sulfonated d-glucosamine, as shown in Figure 1.1.4 (Lin-
dahl et al., 1979; Shriver et al., 2012). The l-iduronic acid can sometimes be
replaced by its epimer d-glucuronic acid, and the sulfation pattern can also
vary along the polysaccharide chain, contributing to a complex structure of
these polysaccharides (Shriver et al., 2012).
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Figure 1.1.4: The major repeating disaccharide unit of the heparin structure
in its fully sulfated form. The l-iduronic acid can sometimes be replaced by
its epimer d-glucuronic acid, and the sulfation pattern can also vary along
the polysaccharide chain (Shriver et al., 2012).
Heparin interacts with hundreds of different proteins, including growth fac-
tors such as fibroblast growth factor (FGF), enzymes such as thrombin, and
matrix proteins such as fibronectin (Linhardt, 2003). Heparin is used exten-
sively clinically as an anticoagulant, as it can bind to antithrombin and slow
down the coagulation process (Linhardt, 2003; Lindahl et al., 1979). It is a
naturally occurring polysaccharide produced mainly in mast cells found in
organs such as liver, intestines and lung (Linhardt, 2003) Heparin is isolated
from animal tissue, mostly porcine intestine, and goes through an exten-
sive purification process before it can be used as a pharmaceutical product
(Shriver et al., 2012). The expensive and time-consuming process to obtain
heparin makes it attractive to develop heparin analogues that can be made in
a more rapid and cost effective way. Tailored heparin analogues also allow for
a more controlled structure, with less variability than the heparin extracted
from animal tissue. Heparin analogues produced by researcher groups so
far include polyglycerol sulfates, pentosan polysulfate and alginate sulfates
(Tu¨rk et al., 2004; de Prost, 1986; Ronghua et al., 2003; Zhao et al., 2007).
Sulfation of alginate have been obtained by two different approaches. One
of the approaches includes a conversion of a sodium salt to a tertiary amine
salt followed by O-sulfation with carbodiimide and sulfuric acid (Freeman
et al., 2008). This approach was found to cause some depolymerization of
the samples during the sulfation process (Freeman et al., 2008). Ronghua et
al. used another approached, where formamide and chlorosulfonic acid were
added to alginate followed by heating to 60 ◦C for 4 h to obtain alginate
sulfate with 1.4 sulfate groups per uronic acid on average (Ronghua et al.,
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2003). The maximum degree of substitution, or degree of sulfation (DS)
theoretically posssible is 2, corresponding to sulfate substitution on both the
available hydroxyl groups on each residue in the polysaccharide chain (Arlov
et al., 2014). Using the Ronghua method, Arlov et al. reported maximum
values for DS of 1.15 for poly-G alginate and 0.9 for poly-M alginate. They
also observed an increase in DS for increasing concentrations of HClSO3 in
the reaction mixture up to 4 % (v/v) HClSO3, where the DS value reached
a plateau, possibly due to a decrease in the alginate solubility as the acidity
of the solution increases (Arlov et al., 2014). The sulfation process for this
method is probably random, shown by a greater heterogeneity in sulfation
patterns for samples of moderate degrees of sulfation of 0.4-0.5 than for sam-
ples close to saturation (Arlov et al., 2014).
Alginate sulfate has shown some anticoagulant activity by prolonging the
activated partial thrombosis time (ATTP) to almost the same degree as hep-
arin (Ronghua et al., 2003). Heparin binding proteins have also been shown
to bind to both heparin and alginate sulfate, but not to alginate (Freeman
et al., 2008). Mixtures of alginate and alginate-sulfate were able to produce
beads that caused a slower release of basic FGF (bFGF) into the surrounding
medium compared to pure alginate beads (Freeman et al., 2008). Scaffolds
containing mixtures of alginate and alginate-sulfate with bound bFGF im-
planted in rats increased the angiogenetic activity and led to a higher matu-
rity of the formed vessels compared to the pure alginate scaffolds (Freeman
et al., 2008). Alginate sulfate has also been immobilized onto polysulfone
ultrafiltration membranes to give selective binding of low-density lipoprotein
(LDL) in blood. High levels of LDL, a major cholesterol transporter in the
blood, is associated with an increased risk of atherosclerosis and heart at-
tacks, and LDL adsorbents are used to reduce this risk (Wang et al., 2014).
The immobilized alginate sulfate had a good blood compatibility, and LDL
could be desorbed by addition of NaCl, making therapeutical reuse of the
membranes possible (Wang et al., 2014). The bicompatbility and the ability
to interact with proteins makes sulfated alginate a possible candidate for use
in tissue engineering.
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1.2 Tissue Engineering
1.2.1 Properties of Scaffolds for Use in Tissue Engi-
neering
The number of patients in need of an organ transplantation far exceeds the
number of available donors, resulting in the death of patients as they wait
for a suitable donor. This has brought forward the field of tissue engineering,
where the idea is that new and functional tissue can be fabricated using liv-
ing cells associated with a scaffold guiding tissue development (Lanza et al.,
2011). These scaffolds must be biocompatible, accommodate cell adhesion,
proliferation and vascularization, be able to organize cells into three dimen-
sional structures, provide a mechanical support for the growing tissue and
ensure that nutrients and metabolites are free to diffuse to and from the cells
(Rowley et al., 1999a; Bose et al., 2012). The extracellular matrix (ECM)
associated with cells in the body affects both cell growth and differentiation
as well as tissue strength and structure, and scaffolds imitating the ECM
should be able to interact with cells in a similar manner (Shoichet et al.,
1996).
The ideal mechanical strength of the scaffold should match the desired tissue,
and as the Young’s modulus of tissues ranges from less than 1 kPa for liver,
via 25 kPa for skeletal muscle cells and 100 kPa for cardiac cells, and up to
as high as 20 GPa for bone, the mechanical requirements of scaffolds vary
greatly (Bose et al., 2012; Ashman et al., 1984; Yoon and Katz, 1976; Chen
et al., 1996; Mathur et al., 2001). The scaffolds can be made using materials
that are permanent or biodegradable, natural, synthetic or hybrids (Lanza
et al., 2011). Biodegradable materials must have a controlled degradation
rate, matching the development of the newly formed tissue, giving room for
this as it grows (Bose et al., 2012).
The scaffold permeability is essential for the distribution of cells through-
out the whole scaffold, and for the flow of nutrients and oxygen (Melchels
et al., 2010). Not only the pore size, but also the size of the interconnec-
tion channels is important for a good cell distribution, as cells seldom enter
interconnections smaller than 5-10 times the size of a single cell (Melchels
et al., 2010). Porous scaffolds involving both micro- (< 20µm) and macro
(> 100µm) porosities is an advantage to cell growth (Bose et al., 2012). As a
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high porosity compromises the mechanical strength, this can be a challenge
when making scaffolds with the requirement for a high mechanical strength
(Bose et al., 2012). Carefully engineered surfaces and pore sizes of scaffolds
can also help guide the alignment of cells such as muscle cells, where the
cell orientation is important for the function of the tissue (Guillemette et al.,
2010; Engelmayr et al., 2008).
Cells can be seeded in the scaffold before implantation, or they can be re-
cruited in vivo (Lanza et al., 2011). Co-seeding of different cell types in vitro
can increase the levels of vascular endothelial growth factor expression in the
construct and promote formation and stabilization of the endothelial vessels
after implantation (Levenberg et al., 2005). As tissues are often composed of
more than one single cell type, the scaffold must be able to accommodate and
guide the development of several cell types at the same time (Lanza et al.,
2011). Biomolecules such as growth factors and differentiation factors can be
incorporated into the scaffold to help the vascularization, cell differeniation
and growth in and around the graft, and to guide the development of the
desired tissue (Lanza et al., 2011; Bose et al., 2012).
1.2.2 Alginate Hydrogels as Scaffolds
Hydrogels are hydrophilic three-dimensional polymeric networks containing
more than 30 % water, and are attractive materials in the field of tissue
engineering as they have physical properties similar to many tissues (Pep-
pas et al., 2000; Drury and Mooney, 2003). Alginate is one of the natural
polymers used to create hydrogels for use in tissue engineering. Alginate hy-
drogels have been used as injectable cell delivery vehicle, as wound dressing,
dental impression, immobilization matrix, as a synthetic extracellular matric
(ECM) and for transplantation of chondrocytes, hepatocytes and islets of
Langerhans (Lee and Mooney, 2001; Drury and Mooney, 2003; Augst et al.,
2006; Rowley et al., 1999a).
Alginate is an attractive material for applications like the ones mentioned
because of its biocompatibility, the possibility of gelation under mild con-
ditions, allowing for incorporation of proteins or live cells and because it is
readily available and relatively easy to modify (Rokstad et al., 2011; Drury
and Mooney, 2003; Augst et al., 2006; Mørch, 2008). The porosity of the
alginate gels can be regulated by changing concentrations and G/M-ratio in
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the gels (Gombotz and Wee, 2012b). The porosity of gels can be monitored
by use of electron microscopy, diffusion studies with proteins of different
molecular weights, or by packing of gels in a column and recording the ex-
clusion volumes for macromolecular standards (Gombotz and Wee, 2012b).
Alginate hydrogels can be moulded into complex geometries to make suitable
scaffolds (Kuo and Ma, 2001). Unfortunately, alginate also has some weak-
nesses for tissue engineering applications, the most important ones being the
poorly regulated degradation rate, and the lack of cell adherence (Rowley
et al., 1999a; Augst et al., 2006; Rowley et al., 1999b). Alginate gels also
experience a rapid drop in mechanical strength initially in physiological so-
lutions, but composites, e.g polymers and ceramics can be used to maintain
the strength if a high mechanical strength is required for a longer period of
time (Bose et al., 2012; LeRoux et al., 1999).
For applications such as release of incorporated biomolecules or in functional
tissue regeneration, a controlled degradation rate is essential to the function
of the hydrogel (Drury and Mooney, 2003; Augst et al., 2006). Ionically
crosslinked alginate gels experience a slow and uncontrolled degradation in
vivo as the crosslinking ions leak out of the hydrogel and the gelation junc-
tions are disrupted (Augst et al., 2006). Methods used for improving the
control over the degradation rate of ionically crosslinked alginate hydrogels
includes producing methacrylated photocrosslinked gels, also allowing for
control of swelling behavior and the elastic modulus, and the mixing of high-
and low molecular weight partially oxidized alginates (Jeon et al., 2009; Kong
et al., 2004). Alginates can also be crosslinked covalently by use of carbodi-
imide chemistry to control the stability of the gel (Rowley et al., 1999b).
The hydrophilic surface of alginate hydrogels does not incourage cell adhesion
of either eukaryotic or prokaryotic cells, and lack the ability of interaction
with proteins (Smetana Jr, 1993; Rowley et al., 1999b). Cell anchorage is
critical for the survival for many cell types, and is also involved in cell mi-
gration, proliferation, differentiation and apoptosis (Rowley et al., 1999b). A
way to improve the ability of alginate to interact biologically is by coupling
cellular adhesion molecules such as laminin, fibronectin or collagen to the
alginate (Augst et al., 2006). Short amino acid sequences found in the ECM,
such as fibronectin-derived peptide arginin-glycine-aspartic acid (RGD), or
derivates of such sequences, are often used for obtaining biological activity
(Augst et al., 2006). Myoblasts have been shown to adhere to, proliferate and
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fuse in contact with RGD-modified alginate gels, and a co-transplantation of
osteoblasts and chondrocytes in alginate-RGD gels led to self-organization
into growth plate-like structures (Augst et al., 2006; Rowley et al., 1999b).
1.2.3 Alginate Gel Beads
The mild conditions for alginate gel formation makes it possible to entrap
living microbial or mammalian cells inside alginate gels by mixing them into
the alginate solution prior to gelation (Martinsen et al., 1989). The inhomo-
geneity obtained by use of external gelation is often a preferred structure in
microcapsules due to low porosity and high stability (Strand et al., 2003a).
One application of alginate microcapsules is as immune barriers for cell trans-
plantation, where the alginate bead protects the entrapped cells from the host
immune system (Mørch et al., 2006). This method for cell transplants does
however involve problems such as early graft rejection due to overgrowth by
fibroblasts, as well as chemical and mechanical instability of the capsules
(Moe et al., 1993).
In order to stabilize the microcapsules against osmotic swelling, the algi-
nate beads are often coated with a polycation, such as poly-l-lysine (PLL)
(Orive et al., 2006). As PLL is known to activate immune responses in blood,
a final coat of alginate is often applied, giving alginate-PLL-alginate (APA)
microcapsules. (Orive et al., 2006). However, this extra coating does not
fully mask the immunogenic activity of PLL, and is not an optimal sys-
tem (Rokstad et al., 2011; Orive et al., 2006). Coating with poly(ethylene
glycol)-grafted PLL or use of hydroxyethyl methacrylate-grafted alginate are
methods to improve the biocompatibility of the microcapsules without loss
of stability (Shoichet et al., 1996).
The sensitivity of Ca2+-gels towards chelating agents such as phosphate and
citrate, as well as nongelling ions such as Na+ and Mg2+ is one reason for
gel instability. In a physiological solution the ion replacement in the gel will
lead to osmotic swelling of the beads or microcapsules, where the pore size
increases and the gel is eventually destabilized and prone to rupture (Thu
et al., 1996). The non-condensed ions in the alginate network, such as Na+
and Ca2+, are held back from diffusing out into a solution with a lower chem-
ical potential by the negative charges of the alginate backbone. This causes
an osmotic pressure inside the gel and an inflow of water (Moe, 1993). In a
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stable gel the osmotic pressure will be balanced by the elastic and retracting
reaction of the gel network and the volume will stay constant (Moe, 1993).
In a NaCl solution, the sodium ions can replace Ca2+ or Ba2+ ions in the
gel structure, causing the release of these ions into the medium, giving a
reduction in the gel strength (Martinsen et al., 1989). A high crosslinking
ratio and few hydrophilic groups are some factors that will give a hydrogel
with less swelling (Peppas et al., 2000).
1.3 Fibroblast Growth Factors (FGFs)
Fibroblast growth factors (FGFs) are part of a large family of polypeptide
growth factors, where the first isolated members were acidic FGF (aFGF)
and basic FGF (bFGF) (Gospodarowicz, 1975; Johnson et al., 1990). FGFs
are found in a wide range of organisms, from nematodes to humans (Ornitz
and Itoh, 2001). They are involved in the regulation of cell proliferation,
migration, morphogenesis, angiogenesis and differentiation during embryonic
development, and act as homeostatic factors and contribute to tissue repair
in adult organisms (Linhardt, 2003; Ornitz and Itoh, 2001). Whereas most
FGFs are readily secreted from the cell, some members of the family are
only existing intracellularly (Ornitz and Itoh, 2001). The role of FGF on cell
development depends on the microenvironment, where both mechanical and
chemical factors influence the effect of FGF on cells (Ingber and Folkman,
1989).
An important part of the biology of FGFs is their ability to interact with
heparin or heparan sulfate proteoglycan (Ornitz and Itoh, 2001). These in-
teractions protects FGF from acidic, thermal and proteolytic degradation.
(Ornitz and Itoh, 2001; Gospodarowicz and Cheng, 1986). Binding to hep-
arin or heparan sulfate has also been shown to increase the diffusion radius
of bFGF in agarose and fibrin gels, and on a cellular monolayer, increasing
the range of action of one single protein (Flaumenhaft et al., 1990).
The FGFs bind to cell surface receptors called FGF receptors (FGFRs) (Lin-
hardt, 2003). These receptors include both transmembrane tyrosine kinase
receptors and extracellular receptors and are also heparin binding proteins
(Linhardt, 2003; Johnson et al., 1990). Heparin is thought to promote the
formation of a stable FGF:FGFR:heparin ternary complex, and to stabilize
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the interaction with a second similar complex, so that a receptor dimerization
followed by signal transduction can occur (Schlessinger et al., 2000).
1.4 The Young’s Modulus
The Young’s modulus, or the elastic modulus, E, is a measure of the gel’s re-
sistance towards compression, and can be calculated from the initial tangent
of a force-deformation curve obtained from a longitudinal compression test
(Draget et al., 1993). The calculation also requires knowledge of the initial
height of the gel, and of the crossectional area of the gel surface, as shown
in Equation 1.4.1 (Draget et al., 1994).
E = F∆l ×
l
A
(1.4.1)
where E is given in N/m2 (Pa), F∆l is the initial slope of the force-distance
plot, where the gel with initial length l, is compressed a distance ∆ l, and A
is the initial cross-sectional area of the gel.
Alginate gel strength is correlated to the content of G residues in the polymer,
the length of the G-blocks, the alginate concentration and molecular weight,
and the choice of divalent cation for gelation (Draget et al., 1990; Mørch
et al., 2012; Smidsrød et al., 1972). MG-sequences can also contribute to an
increase in gel strength, due to the formation of mixed junctions between
G-blocks and MG-blocks (Mørch, 2008). An increasing pore size in alginate
hydrogels is correlated to a decrease in the gel strength (Shoichet et al., 1996).
While use of Ba2+ as gelling agent can improve the mechanical strength of
alginate gels, its use alone is not suited for biological applications, as barium
in its soluble state is toxic to humans, leading to conditions such as extra-
cellular hypokalemia, renal failure and cardiac arrest (Dart, 2004). However,
some experiments have been conducted where both 1 mM BaCl2 and 50 mM
CaCl2 were used together in the gelling bath to form gel beads for use in
microencapsulation (Mørch et al., 2012). These beads had a higher junction
formation and gave stiffer gels than pure CaCl2 gels, and when implanted in
mice, the concentration of barium in the blood did not exceed the estimated
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tolerance set by WHO at 0.02 mg barium/kg body weight per day (Mørch
et al., 2012). Use of low concentrations of barium may thus be possible for
gels in biological applications to improve the stability and strength of the gels.
A linear relationship has been observed between the stiffness and the square
of the concentration of alginate gels (Smidsrød et al., 1972). As alginate gels
often undergo syneresis, the actual alginate concentration is often higher than
the initial concentration of the gel solution, and the measured gel strength
should be corrected for the increase in concentration for more accurate com-
parison between different gels (Martinsen et al., 1989). Assuming the weight
of the alginate gel before and after syneresis is known, the corrected gel
strength can be calculated as shown in Equation 1.4.2 (Martinsen et al.,
1989).
Ecorrected = Emeasured ×
(
wt
w0
)2
(1.4.2)
1.5 Laser Scanning Confocal Microscopy
Laser scanning confocal microscopy (LSCM) is widely used by researchers
and for medical applications, and can offer several advantages over the con-
ventional widefield optical microscopy (Olivier and Moine, 2013). LSCM
offers the ability to control depth of field, to collect serial optical sections
from thick specimen, and excludes secondary fluorescence from other planes
than the one studied at the time. The result is that the images acquired by
use of a confocal microscope is less blurred and reveal a significantly higher
degree of structural detail than images from conventional widefield optical
microscopy (Olivier and Moine, 2013).
In a laser scanning confocal microscope illumination of the sample from a
laser light source, and the detection are confined to a single, diffraction-
limited point in the specimen (Paddock, 2000). The laser light is focused by
use of an objective lens and a raster scanning mechanism is used for scanning
across the specimen, giving what is known as a point scanning of the sample
(Paddock, 2000; Murphy and Davidson, 2013). Lasers for fluorophore excita-
tion includes Argon-ion, Helium-neon, diode and diode-pumped solid state,
which together provide excitation lines across the visible spectrum (Paddock,
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2000). Points of light from the specimen are detected by a photomultiplier
tube (PMT) detector positioned behind a pinhole and a barrier filter, and
only a small fraction of background noise reaches the PMT detector (Pad-
dock, 2000). Analog-to-digital converters changes the voltage fluctuations
of the PMT detector into digital signals for image display on the computer
monitor (Murphy and Davidson, 2013).
1.6 Structural Characterization
1.6.1 HR-ICP-MS
High resolution inductively coupled plasma mass spectrometry (HR-ICP-MS)
is used in a wide range of research fields, including environmental, geological
biomedical and nuclear research fields (Gießmann and Greb, 1994; Thomas,
2013). It is an effective method for rapid multielement determinations from
down to the low range of parts per trillion (ppt) and up to the parts per
million (ppm) range (Thomas, 2013).
In ICP-MS, the liquid sample is pumped into a nebulizer and converted
to a fine aerosol by the use of argon gas (Thomas, 2013). In a spray cham-
ber, the fine droplets (about 1-2 % of the sample) is separated from larger
droplets and enters a plasma torch via a sample injector (Thomas, 2013).
At the plasma torch, temperatures above 6000 K ensures drying, vaporiza-
tion, atomization and finally ionization even of elements with high ionization
potential, sending positively charged ions towards the mass spectrometer
(Gießmann and Greb, 1994). The ions pass through the ion optics, where a
series of electrostatic lenses focus the ion beam towards the mass separation
advice, keeping photons, particulates, and neutral species from reaching the
detector (Thomas, 2013).
At the mass separation device, which for HR-ICP-MS would be a magnetic
sector based high resolution analyzer, only analyte ions of a particular mass-
to-charge ratio are allowed to pass through to the detector, while other ions
are filtered out (Gießmann and Greb, 1994). An ion detector, usually a de-
screte dynode detector, converts the ions into an electrical signal, which is
in turn converted into analyte concentration by use of calibration ICP-MS
standards (Thomas, 2013).
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1.6.2 SEC-MALLS
The molecular weight of polymers is important for their physical properties,
and methods for calculating the molecular weight of samples are frequently
used (Smidsrød and Moe, 2008). In some samples, such as with alginate, the
molecular weight of the polymer chains vary between the molecules in the
sample, and the sample is said to be polydisperse. The average molecular
weight of these polymers can be calculated in different ways, where the num-
ber average molecular weight, Mn, and the weight average molecular weight,
Mw, are the most common ones (Smidsrød and Moe, 2008). The definitions
of these averages are shown in Equation 1.6.1 and Equation 1.6.2.
Mn =
∑
iNiMi∑
iNi
(1.6.1)
where Ni is the number of molecules with molecular weight Mi.
Mw =
∑
iwiMi∑
iwi
=
∑
iNiM
2
i∑
iNiMi
(1.6.2)
where wi is the weight of molecule number i.
The degree of polymerization, DP is defined as the number of monsaccha-
rides per polymer chain, and can be calculated as shown in Equation 1.6.3
(Smidsrød and Moe, 2008).
DP = M
M0
(1.6.3)
where M can be either Mn or Mw, and M0 is the molecular weight of one
single monosaccharide in the chain.
Lastly, the polydispersity index, the ratio between Mw and Mn can give
information about how polydisperse the sample is. A monodisperse sample
would have an index of 1, while for a randomly degraded polymer sample,
the polydispersity index is usually close to 2. (Smidsrød and Moe, 2008).
Size exclusion chromatography (SEC) is by far the most convenient and pop-
ular method for determining the average molecular weight and the molecular
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weight distribution of a sample (Mori and Barth, 1999). SEC optimally sep-
arates solely on the basis of hydrodynamic volume or size, and consists of
a solid phase of porous particles with a known pore size packed in a col-
umn, and a mobile phase (Mori and Barth, 1999). The mobile phase must
have known pH and ionic strength, as these parameters affect the elution be-
haviour of the sample, and should have a composition preventing adsorption
of the sample to the packing material or damage to the solid phase (Barth
et al., 1996).
The sample is dissolved in a solvent, usually the same solvent used as the
mobile phase, and injected into the column (Mori and Barth, 1999). Sample
molecules that are too large to enter the pores of the packing material follow
a path around the packing material and are eluted from the column first.
Smaller molecules enter the pores of the packing material and spend more
time getting through the column, giving a separation based on size for the
macromolecules (Mori and Barth, 1999).
Multiangle laser light scattering (MALLS) is used together with SEC to
give a more accurate estimate of the average molecular weight of the sam-
ple (Podzimek, 2003). The method is based upon the ability of light to
displace the electron cloud of molecules, creating oscillating dipoles which
become sources of radiation that can be detected (Podzimek, 2011). The
tendency of displacement of the electron cloud by light interaction varies be-
tween different molecules, and is proportional to the specific refractive incre-
ment (dn
dc
) of the molecule (Podzimek, 2011). To compute average molecular
weights, dn
dc
and the second virial coefficient, A2, which depend on the solvent-
molecule interactions, must be known (Podzimek, 2003, 2011). The value of
dn
dc
changes when the molecule is chemically modified, and has been shown to
decrease with an increasing number of sulfate groups for the polysaccharide
carrageenan (Berth et al., 2008). The dn
dc
for unmodified alginates has been
determined to be 0.150 ml/g in 0.05 NaSO4 at pH 6, and 0.154 ml/g in 0.1
M NaCl at pH 7 (Vold et al., 2006; Mackie et al., 1980).
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1.7 Characterization of Biological Properties
1.7.1 Flow Cytometry
Flow cytometry is a fast and effective method using light scattering and emis-
sion from dyes or fluorochromes to determine physical and chemical proper-
ties of single cells in suspension (Shapiro, 2005; Leach et al., 2013). Some
of the properties that can be determined by use of flow cytometry are cell
size, nuclear complexity, cytoplasmic granularity, DNA content and protein
expresion (Leach et al., 2013; Gronthos et al., 2001).
In flow cytometry, the sample is inserted in a stream into the center of a sec-
ond stream of fluid, called a sheath fluid (Shapiro, 2005). The two streams
are under pressure, and before the cells pass the laser beam used as the il-
lumination source, the sample stream is focused in the middle of the sheath
stream, forcing the sample cells into a single file (Leach et al., 2013). The
measurement region where the laser beam hits the passing cells is placed in a
flat-sided quartz cuvette to minimize noise from the surroundings (Shapiro,
2005). Argon, krypton and helium-cadmium lasers are used as illumination
sources to cover a wide range of wavelengths for larger systems, while smaller
systems often use a single argon laser with a wavelength of 488 nm. The laser
is focused by lenses before it hits the sample cells (Shapiro, 2005). The light
is scattered at small angles forward and at side angles up to 90 ◦ by the cells
according to physiological properties (Leach et al., 2013). A beam stopper
stops the illuminating beam after it has tranversed the cuvette, and before it
can be detected at the forward scatter detector (Shapiro, 2005). A forward
scatter collection lens focuses the forward scattered light towards the detec-
tor, while fluorescence and side scattered light is focused by collection optics
and directed towards detectors for different wavelength by use of dichroic
mirrors and optical filters (Shapiro, 2005). At the detector, the photons
are converted to electrical signals, and a numerical value is generated for
the pulse height, width and area and assigned to a channel number by an
analogue-to-digital converter (Leach et al., 2013).
The fluorescence intensity of any captured event is recorded by the flow
cytometer for the relevant channel (Leach et al., 2013). After many events
have been captured, the mean fluorescence intensity can be derived, giving
valuable information about the occurrence of the labelled substance in the
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sample (Leach et al., 2013). When using several fluorescence labels or dyes,
compensation for fluorescence emission spectral overlap should be carried out
in cases when emission from one fluorochrome can cause noise at a detector
intended for another fluorochome (Shapiro, 2005).
1.7.2 ELISA
Enzyme-linked immunosorbent assay (ELISA) is a method for detecting an-
alytes, usually antigens, by use of enzymes as reporters (Engvall and Perl-
mann, 1971). The capture system, the analyte and the detection system
make up the assay (Butler, 2000). There are many different assay configu-
rations, but a principle they all have in common is that the analyte must be
the limiting component in the assay. One of the common configurations is
a sandwich-ELISA in which a capture antibody is immobilized on a surface,
usually in the wells of an ELISA plate, before the analyte is added, binding
specifically to the antibody. Detergents or blocking agents in buffers prevents
nonspecific binding of proteins to the solid phase (Butler, 2000). Detection
antibodies are added to the system and bind to the analyte. Either the de-
tection antibody itself or a secondary antibody is conjugated to an enzyme,
catalysing a reaction that usually leads to color development when a suit-
able substrate solution is added to the plate wells (Butler, 2000; Engvall and
Perlmann, 1971). The color development can be detected by use of a plate
reader, and compared to a standard to quantify the amount of analyte in
each well (Butler, 2000).
As the solid phase is rinsed with a buffer solution between every step, the
only enzymes catalysing a reaction are those associated with the presence
of the analyte (Engvall and Perlmann, 1971). At least 15 different enzymes
have been used as signal detectors, with horseradish peroxidase (HRP), al-
kaline phosphatase (AP) and β-galactosidase being the most common ones.
Each of these can be used with different substrates (Butler, 2000). The sig-
nals from the catalysed reaction can also be amplified by use of cascades,
making it possible to detect analytes down to just a few molecules (Engvall
and Perlmann, 1971).
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1.8 The aims of the study
The main objective of this master thesis was to investigate the properties of
alginate/alginate-sulfate mixtures with respect to its suitability as a tissue
engineering material. This includes determining the effect of different mixing
proportions on properties such as gel strength, stability under physiological
conditions and interactions with the protein fibroblast growth factor (FGF).
The distribution of alginate-sulfate in gel microbeads made from alginate/alginate-
sulfate was also studied under different conditions to investigate how the
properties of alginate microcapsules for use in cell transplantation can be
tuned using different storage solutions.
To make mixtures of alginate/alginate-sulfate attractive for use in tissue
engineering scaffolds, the mixtures should be able to form gels of a tunable
mechanical strength and to keep their initial shape in biological solutions
over time. Interaction with proteins such as FGF and a controllable release
of proteins from hydrogels are also desirable properties of a scaffold material.
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2. Materials and Methods
A risk assessment was conducted prior to the master project to identify poten-
tial hazards associated with the work in the laboratory. The risk assessment
is shown in Appendix A.
2.1 Materials
The water used to dissolve alginate under sulfation and preparation of gel
cylinders and beads was Milli-Q (MQ) filtered and deionized water, that has
a resistivity of 18.2 MΩ×cm at 25oC. The water was dispensed through a
0.22 µm Millipore filter. The Protanal LF200S alginate that was sulfated,
Lot.no S21483 was bought from FMC Biopolymer AS, and has the properties
FG = 0.68, FGG = 0.57 and Mw = 250 000 g/mol. Alginate Pronova UP LVG
used in the gel beads for the distribution experiments together with the fluo-
rescence labelled sulfated alginate was purchased from NovaMatrix R©, FMC
BioPolymer, and have an FG of at least 0.60.
For use in the fluorescence labelling, 2-(N-morpholino)ethanesulfonic acid
(MES), N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC),
N-Hydroxysulfosuccinimide sodium salt (Sulfo-NHS) and Fluoresceinamine
were all purchased from Sigma-Aldrich AS (Oslo, Norway).
Formamide, acetone, CaCl2, BaCl2, HNO3, d-Mannitol, ethylenediaminete-
traacetic acid disodium salt dihydrate (EDTA) and NaCl from Merck Mil-
lipore was purchased from VWR AS (Oslo, Norway). 99 % chlorosulfonic acid
(HClSO3), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and
D-glucono δ-lactone (GDL) was purchased from Sigma-Aldrich AS (Oslo,
Norway). The CaCO3 use for gelling was ’Eskal 50’ (average particular size
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5 pm) from KSL Staubtechnik GmbH (Lauingen, Germany).
The cells used in the flow cytometry for assessing the ability of alginate
to bind FGF was RPMI-8226 (American Type Culture Collection, Rockville,
MD, USA). The cells were cultured in RPMI 1604 (Gibco, Paisley, UK) sup-
plemented with l-glutamine (100 µg/ml) and gentamicin (20 µg/ml) with 20
% fetal calf serum (FCS). The cells were cultured at 37 oC in a humidified
atmosphere with 5 % CO2, and the growth medium was replenished twice
weekly. Recombinant Human FGF-basic derived from E.coli and antibod-
ies used for labelling were produced by R&D System R© (Minneapolis, MN,
USA). The antibodies used for primary labelling were anti-FGF basic, FGF
basic Affinity Purified Goat IgG and Mouse IgGl pure. Anti-goat IgG, phy-
coerythrin conjugated donkey IgG was used for secondary labelling.
For studies of the release of FGF-basic from alginate gels, recombinant hu-
man FGF-basic (146 a.a) was purchased from Peprotech R© (New Jersey, NJ,
USA), along with a Human FGF-basic ELISA Development Kit. The ELISA
kit contained antigen-affinity purified rabbit anti-FGF-basic, biotinylated
antigen-affinity purified rabbit anti-FGF-basic, recombinant hFGF-basic and
Avidin-HRP conjugate.
2.2 Sulfation of Alginate
Alginate LF200S was subjected to sulfation by mixing with chlorosulfonic
acid and formamide. The reaction mixture consisted of 2.7 % (w/v) alginate
and varying amounts of HClSO3 in formamide. There were some variations
in the volumes of the different reaction mixtures, as shown in Table 2.2.1.
The alginate was either in powder powder form, as produced by the manu-
facturer, or in a freeze-dried form. An overview of the amount of HClSO3,
the total reaction volume, and the alginate form used for all the mixtures is
given in Table 2.2.1.
The reaction mixture was placed in an oven at 60◦C and left there under
magnetic stirring for 2.5 hours. Acetone at approximately 4◦C was added
in order to precipitate the alginate. The solution was then subjected to 8
minutes of centrifugation at 4750 rpm at 10◦C in a Beckman Coulter Alle-
graÂő X-15R sentrifuge. The pellet of precipitated alginate was resuspended
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in MQ-water and the pH was adjusted to 7-8 by the addition of 5 M NaOH
dropwise to the solution. The fully dissolved alginate in solution was dialyzed
against 35 mM NaCl, 25 mM NaCl and 3× pure MQ water to remove excess
formamide and ions. After the dialysis step, the solution was freeze dried.
Table 2.2.1: The batches of sulfated alginate prepared, with the given
% (v/v) of HClSO3, the form of the alginate used, and the volume
of each reaction mixture. Batch numbers were only assigned to the
samples where the same amount of HClSO3 was used fro several
sulfation batches. 2.7 % (w/v) alginate was used in every reac-
tion mixture, where formamide and HClSO3 constituted the liquid
volume.
% (v/v)
HClSO3
Batch
Number
Freeze-
dried/Powder
Alginate
LF200S
Rection
Volume [ml]
3.5 1 Powder 60
3.5 2 Freeze-dried 120
3.5 3 Freeze-dried 120
3.5 Mw 45 kDa Freeze-dried 6.8
2.75 Powder 60
2.25 Powder 60
1.75 Powder 60
2.3 Elemental Analysis and the Degree of Sul-
fation
Elemental analysis to determine the content of sulfur in the different alginate
samples was performed by Syverin Lierhagen at the Institute of Chemistry,
NTNU, by the use of high-resolution inductively coupled plasma mass spec-
trometry (HR-ICP-MS). The samples were prepared for analysis by dissolving
5 mg of alginate-sulfate in 0.1 M HNO3.
The data from the elemental analysis were used to find the average num-
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ber of sulfate groups attached to each alginate monosaccharide, the degree of
sulfation, DS. A standard curve for calculations of the DS was constructed
by calculating the percentage (w/w) of sulfur (% S) for samples of a range
of theoretical DS values. For the calculations it was assumed that each
monosaccharide in the alginate chain is associated with one water molecule,
and additionally that one sodium ion is associated with each carboxyl group
and one ion with each sulfate group, giving the expression for the average
molecular weight of one monosaccharide shown in Equation 2.3.1.
Mw = C6O6H5 +H2O + (1 +DS)×Na+ +DS × SO−3 (2.3.1)
An example of the calculation of % S from DS can be seen in Appendix
B together with the constructed standard curve where % S is plotted as a
function of DS. A second degree polynomial was fitted to the curve, and was
used to estimate the DS for each sample from the % S obtained from the
elemental analysis.
2.4 Acid Hydrolysis of Alginate and
SEC-MALLS Analysis
To study the susceptibility of sulfated alginates with different DS values to
acid hydrolysis, LF200S, alginate with a DS 0.27 and DS 0.90 were subjected
to acid hydrolysis. In addition, two samples of alginate LF200S were sub-
mitted to a partial hydrolysis in order to obtain one sample of low molecular
weight and one of the same weight average molecular weight, Mw, as the
highly sulfated sample used in the gel strength measurements. This allows
for an observation of the change in gel strength caused by a decrease in the
molecular weight relative to the expected decrease in modulus from increas-
ing degrees of sulfation.
The alginate was dissolved in MQ-water to a concentration of 1 mg/ml. The
pH of the samples was adjusted to 5.6 by use of 1 M HCl. For the samples
with different DS values the samples were distributed into small glass con-
tainers with 2 ml of sample in each container, and incubated at 95◦C. One
sample container from each alginate sample were removed and rapidly cooled
26
down to room temperature after 0, 10, 20, 30, 50, 100, 150 and 200 minutes
of heating. The the sample for gel strength measurement was distributed in
two bottles each containing 250 ml of the alginate solution, and incubated
for 30 minutes at 95◦C followed by rapid cooling and adjustment of the pH
to 7.
In preparation for SEC-MALLS analysis the samples were filtered through
a 0.8 µm filter and diluted with a NaN03/EDTA solution at pH 6, giving
an alginate concentration of 0.80 µg/ml. Samples from all the batches of
highly sulfated alginate were also prepared for SEC-MALLS analysis. The
SEC-MALLS analysis of the samples was carried out by Ann-Sissel Teialeret
Ulset at the Institute of Biotechnology, NTNU. The dn/dc value was set to
0.150 ml/g for all samples, as used by Vold et al. (Vold et al., 2006). A2 was
set to 5.0000e-0.003 ml×mol×g−2.
The weight average molecular weight, Mw of each of the samples were calcu-
lated by use of the Astra 6.1.1.17 software from WTC. Two measurements
were done for each sample, and the average of these two was calculated.
2.5 Preparation of Alginate Gel Beads for Swelling
Experiments
Alginate gel beads were made from either sulfated alginate with varying DS,
or from mixtures consisting both of alginate-sulfate (DS 0.90 or DS 0.68)
and of unmodified alginate LF200S in varying proportions. A list of the gel
beads produced is given in Table 2.5.1.
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Table 2.5.1: Overview of the alginate gel beads prepared for the
swelling experiments.
Pure Samples
CaCl2 BaCl2
LF200S x x
DS 0.27 x
DS 0.59 x
DS 0.79 x
Mixtures of LF200S and sulfated alginate
CaCl2 BaCl2
DS 0.68 x
DS 0.90 x x
A 1.8 % (w/v) alginate solution was prepared by dissolving 90 mg alginate
in 5 ml MQ- water. A solution for making 20 % DS 0.90 beads would then
consist of 72 mg pure LF200S and 18 mg sulfated alginate with DS 0.90
mixed together with the 5 ml of MQ water. A 3 ml plastic pasteur pipette
was used to drip the solution into a 150 ml bath consisting of 50 mM CaCl2
or 50 mM BaCl2to give spherical gel beads. The gel beads were left in the
gelation bath over night.
2.6 Measuring the Swelling of Alginate Gel
Beads
The alginate gel beads were isolated from the CaCl2 or BaCl2 solution and
transferred to 50 ml centrifuge tubes. The beads were rinsed with 3 × 10 ml
of a 0.9 % (w/v) NaCl solution. After the removal of the last 10 ml of NaCl
solution, 50 spherical beads were placed side by side along a ruler, as shown
in Figure 2.6.1.
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Figure 2.6.1: Measurement of alginate bead diameter of LF200S beads before
the first treatment with 0.9 % (w/v) NaCl.
The total length of the beads along the ruler was used to calculate the average
diameter and volume of the beads. The beads were then transferred back to
the tube using a spatula, and subjected to a 1 hour treatment with 18 ml
of the 0.9 % NaCl solution to an assumed equilibrium. After the treatment,
the NaCl solution was removed, the beads were counted and the total length
of the beads measured to find the average diameter and volume increase.
After the diameter measurements the beads were transferred back to the
tube and 18 ml of new NaCl solution was added for a new 1 hour treatment.
This procedure was repeated until the beads burst from osmotic swelling.
Some of the later treatments within a series of swelling measurements lasted
for several hours and comparisons at this point can therefore only be made
between beads measured within the same experiment.
2.7 Content of Ca2+ in swelling gel beads
The content of Ca2+ in the beads before and during swelling was measured
to find out whether there is any difference between the beads in their ability
to bind and retain Ca2+ in a 0.9 % (w/v) NaCl-solution.
1.8 % (w/v) alginate gel beads where 0, 20 and 40 % of the alginate was
alginate-sulfate were made as described in the section 2.5, using 50 mM
CaCl2 in the gelation bath.
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120 beads from each sample were isolated from the gelation bath and rinsed
with 3 × 10 ml 0.9 % NaCl. 20 of the beads were placed on a tissue for
a few seconds to remove excess water, and transferred to a test tube for
later analysis. The remaining 100 beads from each sample were subjected to
treatments with 20 ml 0.9 % (w/v) NaCl lasting for 30 minutes. The beads
were counted between every treatment. 20 new beads from each sample were
placed on a tissue and transferred to test tubes after 6 and 13 treatments.
The beads were dissolved in 9 mM EDTA and 0.1 M HNO3 before an ele-
mental analysis was performed. Elemental analysis to determine the content
of calcium in the different alginate samples was performed by Syverin Lier-
hagen at the Institute of Chemistry, NTNU, by the use of high-resolution
inductively coupled plasma mass spectrometry (HR-ICP-MS). The sulfate
content of the beads was determined in the same analysis.
2.8 Preparation of Alginate Gel Cylinders
Alginate gel cylinders were prepared from a 2 % (w/v) alginate solution.
The alginate used was a mixture of highly sulfated alginate (DS = 0.77) and
unmodified alginate LF200S. As the sulfation process causes some depoly-
merization of the alginate, three batches of alginate gel cylinders consisting
of mixtures of partially hydrolysed alginate and untreated alginate LF200S
were also prepared to study the effect of lower molecular weights on the me-
chanical strength of the gel cylinders.
To prepare 18.75 ml of the 2 % alginate solution the alginate was dissolved in
MQ-water before CaCO3 in MQ-water was added to give a concentration of
15 mM CaCO3 in the final solution. Degassing by use of a vacuum pump was
done in order to reduce the formation of air bubbles in the gels. MQ-water
was mixed with d-glucono δ-lactone (GDL) and immediately added to the
alginate-CaCO3 solution to 30 mM GDL under stirring. After 10 seconds of
stirring, the solution was transferred to six cylindrical plastic moulds with an
inner diameter of 14 mm and a height of 15 mm. About 2.5 ml solution was
added to each mould, giving a convex meniscus in the moulds. The moulds
were sealed at both ends by use of dialysis membranes and rubber bands, as
shown in Figure 2.8.1.
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Figure 2.8.1: A graphical overwiew of the process of making an alginate
gel cylinder using cylindrical moulds capped at both ends with a dialysis
membrane. The mould is sealed at one end before the alginate solution is
added. The other end is sealed before the mould is placed in a gelation bath
containing 50 mM BaCl2.
The filled moulds were transferred to a bath of 50 mM BaCl2 and left there for
24 hours before the gel cylinders were subjected to a longitudinal compression
test. The moulds were placed in the bath in the way shown in the lower right
corner of Figure 2.8.1 to give an optimal diffusion of calcium into the gel.
BaCl2 was used in the gelation bath instead of CaCl2 as the samples with
the highest content of sulfated alginate were unable to form gels with the use
of CaCl2.
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2.9 Gel Strentgh Measurements
The alginate gel cylinders were subjected to a longitudinal deformation test
by the use of a TA.XTPlus Texture Analyzer with a 5 kg load cell and a 35
mm diameter cylinder aluminium probe. The cylinders were compressed to a
12 mm distance at a compression rate of 0.10 mm/sec. A deformation-force
relationship was obtained by the use of the Texture Exponent software. Six
specimens were compressed for each sample. In an early linear area of the
deformation [mm] -force [N] curve a linear regression was performed. The
slope of the fitted line was used in the calculations of the Young’s modulus,
E. The average Young’s modulus, the standard deviation and the coefficient
of variation were calculated for each sample. An example calculation of the
Young’s modulus for a gel from one of the samples is shown in Appendix G.
From earlier work in my specialization project at the Department of Biotech-
nology, NTNU, the Young’s moduli of samples containing only alginate-
sulfate with different degrees of sulfation have been calculated. These results
were used to compare the effect of using mixtures instead of homogeneous
samples on the gel strength. The Young’s modulus data from this project are
given in Appendix C. The content of sulfate groups in the mixed gels was
converted to an approximate value for degree of sulfation of the whole gel, in
order to be able to compare the results with earlier results of gels made from
sulfated alginate of various degrees of sulfation. Equation 2.9.1 was used to
convert the total sulfate content of the mixed gels to an approximate DS,
DSapp.
DSapp = 0.77× % alginate− sulfate100 (2.9.1)
2.10 Fluorescence labelling of Alginate-Sulfate
Highly Sulfated Alginate with a DS of 0.83 and a molecular weight of about
45 kDa was labelled with fluorescence. This allows for a study of the distri-
bution of alginate-sulfate in gel beads consisting of mixtures of alginate and
alginate-sulfate.
0.5 g of alginate-sulfate was dissolved in 15 ml of MQ- water. A buffer
consisting of 0.2 M 2-(N-morpholino)ethanesulfonic acid (MES) and 0.6 M
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NaCl was prepared by dissolving 1.171 g MES and 1.052 NaCl in 30 ml of
MQ-water before the pH was adjusted to 5.5. 11 ml of the buffer was added to
the alginate solution. N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hy-
drochloride (EDC) and N-Hydroxysulfosuccinimide sodium salt (Sulfo-NHS)
was dissolved in 1 ml buffer each and added to the solution to give 9 mM of
both. The mixture was left under stirring in room temperature for 45 min-
utes before the fluoresceinamine was added. Fluoresceinamine was dissolved
in 1 ml buffer before addition to the solution, and had a final concentration
of 4.5 mM. To get all the fluoresceinamine into the solution, 1 ml of buffer
was used to rinse the beaker, giving the reaction mixture a total volume of
30 ml. The mixture was left under stirring in room temperature for 18 hours.
The solution was filtered through a 0.80 µm filter before it was submit-
ted to dialysis to remove excess fluoresceinamine from the solution. After
leaving the dialysis tube in one initial bucket of pure MQ-water overnight,
the solution was dialysed against 0.1 M NaCl and MQ- water. The pH of
the solution was adjusted to 7.4 and submitted to freeze drying.
2.11 Preparation and Distribution Studies of
Alginate/Alginate-Sulfate Gel Beads
1.8 % (w/v) alginate gel beads were prepared for studies of the distribution of
alginate-sulfate in alginate/alginate-sulfate beads in different solutions. The
beads were made by dissolving UP LVG alginate and fluorescence labelled
alginate-sulfate of DS 0.83 and a molecular weight of about 45 kDa in 0.3 M
d-Mannitol. The alginate-sulfate made up 10 % (w/w) of the alginate in the
solution. The solution was stirred until all the alginate was fully dissolved,
and filtered through a 0.80 µm filter before it was transferred to a 20 ml
syringe.
The syringe was fastened to a GrasebyTM3500 anaesthesia pump set to a
flow rate of 10 ml/h. The syringe was coupled to a plastic tube leading to a
needle placed inside a electrostatic bead generator. The voltage in the bead
generator was set to 7 kV. A bath containing 50 mM CaCl2 in 0.15 M d-
Mannitol under magnetic stirring was placed beneath the needle, causing the
falling droplets to form spherical beads as they hit the gelation bath. The
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beads were left in the gelling solution for 5 minutes before they were dis-
tributed into three different solutions, as shown in Table 2.11.1. The beads
were studied using laser scanning confocal microscopy (LSCM) 15 minutes
after they were transferred to their solutions, and again after one and two
weeks.
Table 2.11.1: The solutions used for storage of alginate gel beads
containing alginate-sulfate labelled with fluorescence.
Solution 1:
NaCl
The beads were rinsed with 3 ×
10 ml of 0.9 % (w/v) NaCl and
stored in 0.9 % (w/v) NaCl with
1 mM CaCl2
Solution 2:
CaCl2
50 mM CaCl2 in 0.15 M
d-Mannitol
Solution 3:
HEPES
20 mM HEPES solution with
154 mM NaCl, 2 mM CaCl2, 0.1
% BSA and 0.02% NaN3, pH 7.4
The alginate gel beads were studied by use of LSCM the same day they
were made, and after one and two weeks after production, to study the
distribution of the sulfated alginate in the beads over time. A Zeiss LSM 510
Confocal Microscope was used with an argon laser at 488 nm, and a 10× Plan
Apochromat/0.45 W objective to study the samples. Pictures of the beads
were acquired and processed by use of the software LSM 510 Image Browser,
version 4.2. All samples were studied by scanning through an equatorial slice
of the sample. An intensity curve was drawn for one bead from each sample
from the intensities measured throughout the center of the bead.
2.12 Interactions Between Alginate-Sulfate in
Solution and FGF
The binding of mixtures of alginate and alginate-sulfate to the heparin bind-
ing protein fibroblast growth factor (FGF) was investigated by the use of flow
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cytometry. The FGF used in the experiment was recombinant human FGF-
basic (rhFGF-basic) isolated from Escherichia coli. The alginate/alginate-
sulfate mixtures contained from 20 % alginate-sulfate with DS 0.90, via 40
%, 60 % and 80 % to 100 % alginate-sulfate.
Stock solutions of alginate/alginate-sulfate were prepared by dissolving 10
mg of mixed alginate and alginate-sulfate in different proportions in 1 ml of
sterile water. These were further diluted in phosphate buffered saline (PBS)
containing 0.1 % bovine serum albumin (BSA) to 10 µg/ml. In addition to
the alginate/alginate-sulfate mixtures used in the experiment, there were also
two samples of pure sulfated alginate with DS 0.27 and DS 0.59. A sample
of 10 µg/ml unsulfated alginate LF200S, an untreated sample and a sample
using a different antibody were used as three different controls.
About 3.9 million myeloma RPMI cells were centrifuged and washed in
PBS/0.1 % BSA, followed by stimulation with 200 µl, 4 µg/ml FGF in
PBS/0.1 % BSA for 10 minutes. After the incubation time, 800 µl of PBS/0.1
% BSA was added to the tube and the cells were centrifuged and resuspended
in PBS/0.1 % BSA.
200 µl of the alginate solutions were transferred to individual flow tubes.
To the tubes for the controls with untreated sample and the Mouse IgG pure
sample, 200 µl PBS/0.1 % BSA was added instead, giving a total of 17 tubes.
Approximately 200 000 cells were added to each tube, and incubated for 10
minutes.
FGF antibody FGF basic Affinity Purified Goat IgG was added to 16 of
the sample tubes, while Mouse IgG pure was added to the last tube as an
isotype control, and the samples were left on ice for 25 minutes. For sec-
ondary labelling, phycoerythrin conjugated donkey IgG was added to all the
tubes and left on ice for 25 minutes. The samples were washed with PBS/0.1
% BSA and centrifuged before and after each labelling step. After the last
centrifugation step, the samples were resuspended in PBS, and the flow cy-
tometer analysis was run to detect the labelled FGF still attached to the cells.
The median fluorescence intensity of cells from each sample was recorded.
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2.13 Release of FGF-basic from Alginate/Alginate-
Sulfate Gels
The release of FGF from gels made of mixtures between alginate and alginate-
sulfate was studied using ELISA. A buffer containing 20 mM HEPES, 154
mM NaCl, 2 mM CaCl2, 0.1 % (w/v) BSA and 0.02 % (w/v) NaN3 was
prepared for use in the experiment.
Alginate gels containing 1.5 % (w/v) alginate were made using LF200S algi-
nate and alginate-sulfate with a DS of 0.77 in different proportions to each
other. The gels also contained 18 mM CaCO3 and 36 mM GDL for an in-
ternal gelation process. Gel solutions where 0, 20, 40, and 60 % of the total
alginate content was alginate-sulfate were prepared. Gel solutions for each of
the four mixtures were made by dissolving mixed alginate/alginate-sulfate in
sterile water before CaCO3 dissolved in sterile water was added. The solution
was degassed by use of a vacuum pump, before FGF-basic was mixed gently
into the solution to a concentration of 2 µg/ml. GDL was dissolved in sterile
water and immediately added to the alginate solution. After 10 seconds of
stirring, 1 ml of alginate solution was added to each of three center wells in
a 4 × 6 well plate, giving a total of 12 filled wells, on two different plates, as
shown in Figure 2.13.1. Only the center wells were used in order to minimize
the loss of liquid from the wells by evaporation.
Figure 2.13.1: The distribution of the gel disks in two 6 × 4 well plates. The
percentages represents how many % (w/w) of the total alginate content is
alginate-sulfate. Each of the four mixtures was distributed between three
different wells.
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The plates were left for 24 hours to allow the gel solution to form gel disks in
the wells. After 24 hours the plates were placed in a heating cabinet holding
37 ◦C and 1 ml of the HEPES solution was added to each well containing a
gel disk. After 30 minutes, 500 µl of the HEPES solution was removed from
each well and transferred to separate wells on another plate for later analysis.
500 µl of new HEPES solution was added to each well containing gel disks.
The two test plates were wrapped up in parafilm to avoid evaporation, and a
beaker containing water was placed in the heating cabinet to ensure a humid
environment. The procedure for taking out samples and replenish the wells
with new HEPES medium was repeated daily for 12 days.
A human FGF-basic ELISA development kit with a sandwich ELISA format,
as well as human recombinant bFGF was bought from PeproTech (Rocky
Hill, NJ, United States). The kit contained antigen-affinity purified rabbit
anti-FGF-basic, biotinylated antigen-affinity purified rabbit anti-FGF-basic,
avidin-HRP conjugate and human FGF-basic standard. The gel disks were
removed from the HEPES solution after 12 days. The height and diameter
of each gel disk were measured before each disk was dissolved in 10.5 ml of
a solution of 7 mM EDTA in sterile water. The solutions containing the
dissolved gel disks were diluted in series of 1/10, 1/100 and 1/1000 of the
original concentrations. The FGF standard was diluted giving a standard
range of 0 to 4000 pg/ml.
The ELISA analysis was carried out for the solution removed from the wells
during the first 12 days, the standard and the dilution series of dissolved gel
disks as described in the protocol from the manufacturer, with the exception
that samples from the 12 days were tested in duplicate and not triplicate
due to the large number of samples. The absorbances were read using a
plate reader set at 405 nm with 650 nm as the reference wavelength. The
absorbance obtained at 650 nm was subtracted from the one read at 405 nm
for the same well, giving a net absorbance for each well read.
The absorbance results obtained from the plate readings were used to cal-
culate the remaining concentration of FGF in the 12 gel disks after 12 days.
The results from the samples taken out from the wells daily were all outside
of the range of the standard. As the standard curve was a second degree
polynomial, and not linear, an extrapolation would not give a good estimate
for the concentration in these samples. An attempt to widen the range of the
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standard to include these samples was not successful. The results from the
plate readings of the solutions containing dissolved gel disks were converted
into FGF concentrations using the calculated standard curve.
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3. Results
3.1 Sulfation of Alginate
Alginate LF200S was sulfated in several batches using formamide and chloro-
sulfonic acid. The resulting alginate-sulfate was subjected to elemental anal-
ysis by HR-ICP-MS to measure the content of sulfur in each sample. The
sulfur content from the elemental analysis, given in µg S/g sample, was con-
verted to % S in the sample before Equation B.7 in Appendix B was used to
calculate the degree of sulfation (DS) of the sample.
The results from the elemental analysis for all three of the sulfated LF200S
alginate samples, together with the conversion to percentage sulfur in each
sample and the calculated DS are all given in Table 3.1.1.
Table 3.1.1: The content of sulfur in all the sulfated LF200S alginate
samples, along with the calculated degree of sulfation (DS). The
percentage (v/v) of chlorosulfonic acid used in the reaction mixture
is given in the names of the samples. Freeze dried alginate, rather
than alginate in powder form, was used in batch 2 and 3 with 3.5
% HClSO3.
Sample µg S/gsample
% S in the
sample DS
1.75 % HClSO3 33 239 3.32 0.27
2.25 % HClSO3 66 461 6.65 0.59
2.75 % HClSO3 84 824 8.48 0.79
3.5 % HClSO3 batch 1 93 590 9.36 0.90
Continued on next page
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Table 3.1.1 – continued from previous page
Sample µg S/gsample
% S in the
sample DS
3.5 % HClSO3 batch 2 82 886 8.29 0.77
3.5 % HClSO3 batch 3 85 632 8.56 0.80
3.5 % HClSO3 Mw 45 kDa 88 356 8.84 0.83
As shown in Table 3.1.1 increasing the content of chlorosulfonic acid in the
sulfation mixture lead to an increase in the resulting degree of sulfation for
mixtures of the same reaction volume. The freeze-dried alginate used in
batch 2 and 3 turned out to dissolve slower in the sulfation mixture than the
alginate powder used in batch 1, and had, as can been seen in Table 3.1.1
a lower degree of sulfation than the alginate in batch 1. The alginate from
batch 2 even had a lower DS than the alginate from the 2.75 % HClSO3
sample. The 3.5 % HClSO3 sample of molecular weight 45 kDa had a DS
somewhat higher than batch 2 and 3 of samples containing 3.5 % HClSO3.
3.2 Molecular Weight
3.2.1 Acid Hydrolysis
Sulfated alginates with DS 0.27 and 0.90, as well as unmodified alginate
LF200S were subjected to acid hydrolysis at 95◦C with pH 5.6 over time
to assess the susceptibility of sulfated alginate to hydrolysis. The resulting
alginate samples were analysed by use of SEC-MALLS to find the molecular
weight averages, with the results given in Table 3.2.1.
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Table 3.2.1: The molecular weight averages of sulfated and nonsul-
fated alginate samples after acid hydrolysis. The hydrolysis was
carried out with alginate concentrations of 1mg/ml at 95◦C with a
pH of 5.6 for 0 to 200 minutes.
Mw [kDa]
Time [min] LF200S DS 0.27 DS 0.90
0 284 159 161
10 229 152 139
20 204 135 131
30 196 127 109
50 157 95 92
100 114 68 67
150 93 53 50
200 81 44 44
In order to calculate the pseudo first order rate constant for the degradation
of the three samples using Equation 1.1.2, 1
Mw
was calculated and plotted
against the time of acid hydrolysis. The plot for each sample was fitted to a
linear regression line, giving the results shown in Figure 3.2.1.
The calculated values for 1
Mw
for all three samples are given in Table D.1, D.2
and D.3 in Appendix D. The molecular weight for an average monosaccharide
in each sample was calculated as shown in Equation D.1 and Equation D.2 in
Appendix D. The average molecular weight of a monosaccharide in a chain
of alginate LF200S is 198 Da, while the average weights in the samples DS
0.27 and 0.90 are 226 Da and 291 Da, respectively.
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Figure 3.2.1: The inverse of the weight average molecular weight as a function
of the time of acid hydrolysis for two sulfated samples with DS 0.27 and 0.90
and for unsulfated alginate LF200S. Each plot is fitted with a linear regression
line, and the formulas for the regression lines are shown in the figure.
Using the slopes obtained from Figure 3.2.1 together with the values for M0
given above, it can be seen from Equation 1.1.2 that the pseudo first order
rate constant, k is given by Equation 3.2.1.
k = 2M0 × the slope (3.2.1)
The slope and the calculated rate constant, k, for each alginate sample is
given in Table 3.2.2.
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Table 3.2.2: The slopes from the plots given in Figure 3.2.1 where
the inverse of the weight average molecular weight was plotted as a
function as a function of the time of acid hydrolysis for two sulfated
samples and one unmodified sample of alginate LF200S. The table
also gives the values of the pseudo first order rate constant, k, for
the random depolymerization of each of the samples.
Sample Slope [kDa−1min−1] k [min−1]
LF200S 4.41E-05 0.017
DS 0.27 8.53E-05 0.039
DS 0.90 8.52E-05 0.050
Figure 3.2.1 shows that the depolymerization data from all samples fall in a
straight line, confirming a random depolymerization. The sulfated samples
show steeper slopes than the unmodified alginate sample, with little difference
between the two sulfated samples. From Table 3.2.2 it can be seen that
the higher proportion of sulfate groups per monosaccharide in the DS 0.90
sample, gives a higher rate constant for the depolymerization for this sample
than for the DS 0.27 sample.
3.2.2 Sulfated Samples
The weight average molecular weight of the sulfated samples DS 0.77, DS
0.82 and DS 0.90 were determined since the sulfation process involves high
temperature and acidic conditions that can cause some reduction in molecular
weight. As a control for the influence of molecular weight in alginate gel
strength, alginate LF200S was subjected to acid hydrolysis for 30 minutes,
to obtain a molecular weight similar to that of the sample with DS 0.77 used
in the gel compression experiments. A sample was also subjected to acid
hydrolysis for 150 minutes, to obtain a low molecular sample for use in the
experiment on distribution of sulfated alginate in microbeads. The results
from the analysis of all samples are shown in Table 3.2.3.
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Table 3.2.3: ]
The weight average molecular weight of unmodified alginate
LF200S, for sulfated samples and for alginate samples subjected
to acid hydrolysis for 30 and 150 minutes at 95◦C and pH 5.6.
Sample Mw [kDa]
LF200S 284
LF200S, 30 min 154
LF200S, 150 min 45
DS 0.90 161
DS 0.77 160
DS 0.82 175
The results in Table 3.2.3 show that the sample that was partially degraded
by acid hydrolysis for 30 minutes has a weight average molecular weight just
slightly below the molecular weight of the sample with a DS of 0.77 used
in the gel compression experiments. The sample DS 0.82 has a somewhat
higher molecular weight than the other samples produced by sulfation with
3.5 % HClSO3. All the sulfated samples have molecular weights far below
the molecular weight of the unmodified alginate LF200S sample.
3.3 Swelling of Alginate Gel Beads
To study the stability of alginate gel beads in solution containing physio-
logical NaCl levels, calcium-alginate beads were prepared and kept in 18 ml
0.9 % (w/v) NaCl with a change of solution every hour. The number of
beads and the average diameter for the beads of each sample were measured
between every treatment.
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3.3.1 Beads from Sulfated Alginate
Alginate gel beads were made by use of external gelation with 50 mM CaCl2
for sulfated alginate samples of DS 0.27, DS 0.59, DS 0.79 and unmodified
alginate LF200S.
The beads made from the sample containing alginate with a DS of 0.79 did
not form proper beads in the CaCl2 solution. The number of beads, the aver-
age diameter and the average increase in volume for each of the other samples
are shown in Table E.1.1, Table E.1.2 and Table E.1.3 in Appendix E.1, while
graphical presentations of the number and the relative volumetric increase
of the beads are given in Figure 3.3.1 and Figure 3.3.2.
Figure 3.3.1: The number of whole alginate beads present in samples made
from alginate with different DS as a function of the number of treatments
with 0.9 % NaCl.
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Figure 3.3.2: The average increase in volume of alginate beads made from
alginate with different DS as a function of the number of treatments with 0.9
% NaCl.
As can be seen from Figure 3.3.1, the beads made from pure sulfated alginate
are very unstable, and even the beads made from the not too highly sulfated
sample with a DS of 0.27, experience a rapid drop in the number of beads,
with all beads gone after seven treatments with 0.9 % NaCl.
3.3.2 Beads from Alginate/Alginate-Sulfate Mixtures
Gelled with CaCl2
Alginate beads were prepared by use of external gelation with 50 mM CaCl2
for mixtures of alginate-sulfate with a DS of 0.68 or 0.90 with unmodified
alginate Protanal LF200S. The percentages given for each sample represent
the percentage of alginate-sulfate in the sample relative to the total alginate
content of the beads.
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Alginate/Alginate-Sulfate Mixtures using a DS 0.90 Alginate-
Sulfate
The number of beads from each sample of mixtures between alginate of
DS 0.90 and LF200S, counted between every measurement is shown in Ta-
ble E.2.1 in Appendix E.2. The 100 % beads containing only alginate-sulfate
of DS 0.90 were unable to form beads and were excluded from the experi-
ment. The measured average diameter of the other beads and the average
increase in volume are given in Table E.2.2 and Table E.2.3 in Appendix E.2.
Graphical representations of the number of beads and the relative increase in
volume as a function of the number of treatments with 0.9 % NaCl is given
in Figure 3.3.3 and Figure 3.3.4.
Figure 3.3.3: The number of whole alginate beads present in samples made
from alginate mixtures with various proportions of alginate-sulfate with DS
0.90 and alginate LF200S as a function of the number of treatments with 0.9
% NaCl.
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Figure 3.3.4: The average increase in volume of alginate beads made from
alginate mixtures with various proportions of alginate-sulfate with DS 0.90
and alginate LF200S as a function of the number of treatments with 0.9 %
NaCl.
Figure 3.3.3 and Figure 3.3.4 show that the stability of alginate gel beads
from DS 0.90/LF200S mixtures decreases as the proportion of alginate-sulfate
increases. The samples containing much DS 0.90 alginate relative to total
alginate content experience a rapid drop in bead number, and a faster in-
crease in the volume compared to samples containing small proportions of
DS 0.90 alginate. The exception to this trend is the sample containing 20 %
alginate-sulfate, which shows a greater stability both in the bead count and
in the relative volume increase compared to the 0 % beads containing only
LF200S.
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Alginate/Alginate-Sulfate Mixtures using a DS 0.68 Alginate-
Sulfate
The number of beads from each sample of mixtures between alginate of
DS 0.68 and LF200S, counted between every measurement is shown in Ta-
ble E.2.4 in Appendix E.2. The measured average diameter of the beads
and the average increase in volume of the beads are given in Table E.2.5
and Table E.2.6. Graphical representations of the number of beads and the
relative increase in volume as a function of the number of treatments with
0.9 % NaCl is given in Figure 3.3.5 and Figure 3.3.6.
Figure 3.3.5: The number of whole alginate beads present in samples made
from alginate mixtures with various proportions of alginate-sulfate with DS
0.68 and alginate LF200S as a function of the number of treatments with 0.9
% NaCl.
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Figure 3.3.6: The average increase in volume of alginate beads made from
alginate mixtures with various proportions of alginate-sulfate with DS 0.68
and alginate LF200S as a function of the number of treatments with 0.9 %
NaCl.
Figure 3.3.5 and Figure 3.3.6 show similar results for the DS 0.68/LF200S
beads as for the DS 0.90/LF200S beads, but with a less marked difference
between the 0 % and the 20 % sample, as well as for the 40 % and 60 % sam-
ple. The 100 % beads of DS 0.68 did form beads in 50 mM CaCl2, although
they were fairly unstable.
The total sulfate concentration of each alginate/alginate-sulfate mixture is
translated into an approximate DS value, and given in Table 3.3.1 along
with the number of treatments with 0.9 % NaCl required before all beads
were gone from each sample of pure alginate-sulfate and of alginate/alginate-
sulfate mixtures.
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Table 3.3.1: The number of treatments with 0.9 % NaCl before all
beads were gone from each sample of pure alginate-sulfate and of
alginate/alginate-sulfate mixtures. The total sulfate concentration
of beads from alginate/alginate-sulfate mixtures are translated into
an approximate (DSapp) for each sample.
Sample DSapp
Number of
Treatments
DS 0.27 0.27 7
DS 0.59 0.59 3
DS 0.79 0.79 0
0 % DS 0.90 0.00 13
20 % DS 0.90 0.18 16
40 % DS 0.90 0.36 11
60 % DS 0.90 0.54 9
80 % DS 0.90 0.72 6
100 % DS 0.90 0.90 0
0 % DS 0.68 0.00 12
20 % DS 0.68 0.14 15
40 % DS 0.68 0.27 13
60 % DS 0.68 0.41 12
80 % DS 0.68 0.54 7
100 % DS 0.68 0.68 3
3.3.3 Beads from Alginate/Alginate-Sulfate Mixtures
Gelled with BaCl2
To investigate whether gelation with BaCl2 would give the same results with
respect to the 0 % sample and the 20 % sample for the DS 0.90/LF200S
beads as gelation with CaCl2, the experiment was repeated using 50 mM
BaCl2 in the gelation bath.
The number of beads from each sample of mixtures between alginate of
DS 0.90 and LF200S, counted between every measurement is shown in Ta-
ble E.3.1 in Appendix E.2. The measured average diameter of the beads and
the average increase in volume of the beads are given in Table E.3.2 and Ta-
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ble E.3.3. Graphical representations of the number of beads and the relative
increase in volume is given in Figure 3.3.7 and Figure 3.3.8.
Figure 3.3.7: The number of whole alginate beads present in samples made
from alginate mixtures with various proportions of alginate-sulfate with DS
0.90 and alginate LF200S as a function of the number of treatments with 0.9
% NaCl. The beads were made by external gelation with BaCl2.
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Figure 3.3.8: The average increase in volume of alginate beads made from
alginate mixtures with various proportions of alginate-sulfate with DS 0.90
and alginate LF200S as a function of the number of treatments with 0.9 %
NaCl. The beads were made by external gelation with BaCl2.
As can be seen from Figure 3.3.7 and Figure 3.3.8 the samples where 60
% or more of the total alginate content was alginate with DS 0.90 showed
the same trend as earlier, with a decreasing stability of the beads as the DS
0.90 content increases. The samples where the DS 0.90 content was 40 % or
below gave beads that stabilised in number and volume after approximately
45 treatments with 0.9 % NaCl. While the 40 % sample experienced a slightly
larger increase in volume than the 20 % and 0% sample, not much difference
can be seen between the two later samples.
3.3.4 The Content of Ca2+ in Swelling Beads
The capacity of gel beads made from alginate/alginate-sulfate to bind up
and retain calcium for gel beads was investigated. The hypothesis was that
a higher content of calcium in the beads containing 20 % alginate DS 0.90
than in the pure LF200S beads could be the cause of the higher stability of
the 20 % beads. Beads containing 0, 20 or 40 % alginate-sulfate compared
to total alginate content were prepared. The beads were rinsed and treated
with 0.9 % NaCl solution, and 20 beads taken out for analysis after 0, 6
and 13 treatments. The beads were dissolved, and the Ca2+ concentration
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determined by use of HR-ICP-MS.
The resulting content of Ca2+ in 20 beads from each samples at different
times is shown in Figure 3.3.9.
Figure 3.3.9: The content of calcium in the 20 beads taken out from each of
three alginate/alginate-sulfate samples after 0, 6 and 13 treatments with 0.9
% NaCl. The percentages given represent the percentage (w/w) of alginate-
sulfate compared to total alginate content.
The results from Figure 3.3.9 indicates that the sample containing 40 % algi-
nate with DS 0.90 retained slightly more calcium than the beads containing
a smaller proportion of sulfated alginate. This difference did however even
out after 6 treatments. Figure 3.3.10 shows the content of sulfur in the 20
beads taken out from the samples after 0, 6 and 13 treatments with 0.9 %
NaCl.
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Figure 3.3.10: The content of sulfur in the 20 beads taken out from each of
three alginate/alginate-sulfate samples after 0, 6 and 13 treatments with 0.9
% NaCl. The percentages given represent the percentage (w/w) of alginate-
sulfate compared to total alginate content.
From Figure 3.3.10 it can be observed that the sulfur content in the beads
is fairly constant throughout the first six saline treatments. There seems to
be some decrease in the sulfur content between the 6th and 13th saline treat-
ment.
3.4 The Young’s Modulus
The Young’s modulus of gels made from alginate DS 0.77/LF200S mixtures
in different proportions were determined by use of a longitudinal compression
test. The initial slope between 0.4 and 0.5 mm in the force- distance plot was
used in the calculations of the Young’s modulus of each sample, according to
Equation 1.4.1.
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The results of the calculations, together with the standard deviation be-
tween the six gel specimen for each sample and the coefficient of variation, is
given in Table 3.4.1. An example calculation of the Young’s modulus of one
of the samples is given in Appendix G.
Table 3.4.1: The Young’s modulus for gels from alginate DS
0.77/LF200S mixtures, along with the standard deviation between
the six specimen of each sample, and the coefficient of variation
(CoV). The % signifies the percentage (w/w) of alginate-sulfate
compared to total alginate content.
Amount of
Alginate-
Sulfate [%]
The Young’s
Modulus E
[kPa]
The Standard
Deviation of E
[kPa]
CoV
0 310 32 0.10
5 289 35 0.12
10 229 18 0.08
20 215 29 0.13
40 205 35 0.17
60 124 18 0.14
80 82 3 0.04
100 26 8 0.33
Because of the syneresis effects of alginate gels, the Young’s modulus for each
sample was corrected for syneresis according to Equation 1.4.2. The resulting
corrected modulus, Ecorr along with the average weight of each gel sample,
the standard deviation and the coefficient of Variation, CoV, of Ecorr are
given in Table H.1 in Appendix H. Table H.2 in the same Appendix shows
the calculated Young’s modulus of three gel samples from mixtures of par-
tially hydrolysed alginate (Mw ≈150 kDa), both before and after correction
for syneresis. It also contains the average gel weights, the standard deviation
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between the six gel specimen for each sample and the coefficient of variation
of Ecorr. Figure 3.4.1 shows the graph for the corrected Young’s modulus as
a function of the content of alginate-sulfate, together with a plot of the cor-
rected Young’s modulus as a function of the content of partially hydrolysed
alginate.
Figure 3.4.1: The Young’s modulus of DS 0.77/LF200S mixtures corrected
for syneresis, along with hydrolysed alginate/LF200S mixtures. The error
bars correspond to one standard deviation in each direction.
The graphs in Figure 3.4.1 show that replacing small amounts of the un-
modified LF200S alginate with either alginate-sulfate or partially hydrolysed
alginate with approximately the same molecular weight as the sulfated sam-
ple, causes a drop in the Young’s modulus. At larger proportions of alginate-
sulfate or hydrolysed alginate in the gels, there is no or little change in the
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Young’s modulus of the gels containing hydrolysed alginate, while the drop
in Young’s modulus continues for larger proportions of alginate-sulfate.
The content of sulfate groups in the mixed gels was converted to a approx-
imate value for degree of sulfation of the alginate sample as a whole, in
order to be able to compare the results with earlier results of gels made from
alginate-sulfate of various degrees of sulfation. The calculated approximate
DS of the mixed gels are shown in Table 3.4.2.
Table 3.4.2: The approximated degree of sulfation for the mixtures of
alginate-sulfate (DS 0.77) and LF200S. The calculations are based
upon the total content of sulfate groups in the alginate sample as
a whole.
% (w/w)
sulfated alginate DSapp
0 0.00
5 0.04
10 0.08
20 0.15
40 0.31
60 0.46
80 0.62
100 0.77
The Young’s modulus corrected for syneresis for both the gels made from
mixtures and gels made from pure sulfated alginate is plotted as a function
of DS and DSapp in Figure 3.4.2.
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Figure 3.4.2: The Young’s modulus corrected for syneresis of DS 0.77/LF200S
mixtures and gels made from pure sulfated alginate of various DS. The error
bars correspond to one standard deviation in each direction.
As shown in Figure 3.4.2 there is no apparent difference between the me-
chanical strength of alginate gels made from DS 0.77/LF200S mixtures and
gels made from pure alginate-sulfate when the total sulfate content of the
gels is approximately the same in both samples.
3.5 Distribution of Sulfated Alginate in Gel
Beads
The distribution of fluorescence-labeled alginate-sulfate in gel beads was
monitored weekly using LSCM over two weeks. The beads were made from
mixtures of alginate Pronova UP LVG and fluorescence-labeled alginate-
sulfate with a DS of 0.83. The alginate-sulfate made up 10 % of the total
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alginate content in the beads.
Figure 3.5.2 shows the distribution of the alginate-sulfate in gel beads stored
in a NaCl solution for two weeks (Solution 1 in Table 2.11.1). In Figure 3.5.2
the distribution of alginate-sulfate when the beads were kept in a solution
containing CaCl2 (Solution 2 in Table 2.11.1) is shown. Figure 3.5.3 shows the
distribution in beads stored in a HEPES solution (Solution 3 in Table 2.11.1).
Figure 3.5.1: The distribution of alginate-sulfate of low molecular weight
in beads stored in a NaCl solution. The fluorescence intensity through the
beads is shown below each picture. The distribution of alginate-sulfate in gel
beads A) immediately after transfer to the NaCl solution; B) after one week
storage; C) after two weeks storage.
60
Figure 3.5.2: The distribution of alginate-sulfate of low molecular weight in
beads stored in a CaCl2 solution. The fluorescence intensity through the
beads is shown below each picture. The distribution of alginate-sulfate in
gel beads A) immediately after transfer to the CaCl2 solution; B) after one
week storage; C) after two weeks storage.
Figure 3.5.3: The distribution of alginate-sulfate of low molecular weight in
beads stored in a HEPES solution. The fluorescence intensity through the
beads is shown below each picture. The distribution of alginate-sulfate in
gel beads A) immediately after transfer to the HEPES solution; B) after one
week storage; C) after two weeks storage.
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From Figure 3.5.1 it is clear that the beads stored in the NaCl solution ob-
tained a homogeneous distribution of alginate-sulfate throughout the beads,
with no apparent change taking place over the two weeks of storage. From
Figure 3.5.2 and Figure 3.5.3 it can be seen that the storage in CaCl2 and in
HEPES both resulted in a distribution gradient of alginate-sulfate through-
out the beads, with a gradual increase in the concentration of alginate-sulfate
towards the surface of the beads. The beads stored in the CaCl2 acquired
uneven surfaces, and many of the beads ruptured during the storage time.
3.6 Interactions between FGF and Alginate/
Alginate-Sulfate
3.6.1 Alginate/Alginate-Sulfate in Solution
Alginate-sulfate of varying degrees of sulfation, as well as mixtures of algi-
nate/ alginate-sulfate (DS 0.80) were used to inhibit binding of FGF to the
surface of myeloma cells. FGF remaining on the cell surface was labelled with
fluorescence and detected by use of flow cytometry. The mean fluorescence
intensity of the cells was recorded and compared to the intensity of a sample
not treated with alginate.
The median fluorescence intensity from the samples were all compared to
the one obtained from cells not treated with alginate. The median fluo-
rescence intensity was measured for cells with labelled FGF treated with
alginates having different degrees of sulfation. The results are given in Fig-
ure 3.6.1. The resulting median fluorescence intensities of cells treated with
alginate/alginate-sulfate (DS 0.80) mixtures are given in Figure 3.6.2.
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Figure 3.6.1: The median fluorescence intensity of cells with labelled FGF
after treatment with alginates of different degrees of sulfation (DS). Results
are given in percent inhibition of FGF-cell binding compared to the untreated
sample.
Figure 3.6.2: The median fluorescence intensity of cells with labelled FGF
after treatment with alginate/alginate-sulfate (DS 0.80) mixtures. Results
are given in percent inhibition of FGF-cell binding compared to the untreated
sample.
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The results from Figure 3.6.1 show that the sample containing alginate with
a DS of 0.27 did not inhibit the interaction between FGF and cells, while
the samples with DS 0.59 and 0.80 did show the ability to inhibit these
interactions. In Figure 3.6.2 there is an increase in the ability to inhibit the
interaction between cells and FGF with a higher content of alginate-sulfate
in the solution. To compare the mixtures and the purely sulfated samples,
an approximate DS (DSapp) was calculated for the mixtures. This value is
based upon the total content of sulfate groups in the whole alginate sample.
The values are given in Table 3.6.1.
Table 3.6.1: The approximated degree of sulfation for the mixtures of
alginate-sulfate (DS 0.80) and LF200S. The calculations are based
upon the total content of sulfate groups in the alginate sample as
a whole.
% (w/w)
sulfated alginate DSapp
0 0.00
20 0.16
40 0.32
60 0.48
80 0.64
100 0.80
As shown in Table 3.6.1 the sample containing 20 % alginate-sulfate has an
approximate DS of 0.16. Figure 3.6.2 shows that this sample has some ability
to inhibit the FGF-cell interaction, in contrast to the pure sulfated sample
with DS 0.27 shown in Figure 3.6.1. After he point where 60 % of the alginate
in the mixed solution is sulfated, no further increase in the inhibition can be
observed.
3.6.2 Release of FGF from Alginate/Alginate-Sulfate
Gel Disks
The release of FGF from alginate/alginate-sulfate gel disks over a 12 day
period was studied by use of ELISA. As the samples were not diluted prior
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to the analysis, the samples fell outside the measured standard, and the mea-
sured absorbance for these samples are reported instead of concentrations.
The remaining content of FGF in the gel disks was measured using ELISA
after 12 days, and the absorbances converted to concentrations of FGF in
the gel disks by use of a constructed standard curve.
The resulting absorbance measurements at 405 nm with 650 nm as a wave-
length reference for the FGF release from gel disks are given in Figure 3.6.3.
Figure 3.6.3: The measured absorbance at 405 nm for in an ELISA with sam-
ples from solutions over gel disks containing FGF. The samples were collected
over a time range of 12 days. 650 nm was set as a reference wavelength, and
the gel disks initially contained 2 µg/ml FGF. The percentage of the sample
represents the content of alginate-sulfate compared to total alginate content.
The error bars represents one standard deviation in each direction.
From Figure 3.6.3 it is clear that FGF is released from all the gel disks, and
the release is observed to be largest the first four days of the experiment.
The calculated FGF concentrations in the gel disks after 12 days are given
in Figure 3.6.4. The values used in the calculations are all given in Table
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I.1 in AppendixI. The standard curve used for these calculations is given in
Figure I.1 in the same appendix.
Figure 3.6.4: The calculated concentration of FGF in gel disks after 12 days
in a HEPES medium. The percentage of the sample represents the content of
alginate-sulfate compared to total alginate content. The results are obtained
from absorbance measurements of 1/10 diluted samples at 405 nm and a
correction wavelength of 650 nm after ELISA.
A series of higher diluted samples showed an overall higher concentration
of FGF in the gels, suggesting some inaccuracy in the assay. However, the
relative difference between the samples remained the same for all dilutions.
The inaccuracies increased with higher dilutions, which is the reason why the
1/10 dilution was used even though the samples from the 60 % gel disks fall
outside the standard curve.
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4. Discussion
Alginate LF200S was successfully sulfated, with the resulting degree of sulfa-
tion (DS) depending mainly upon the concentration of chlorosulfonic acid in
the sulfation mixture, although the solubility of the alginate and the reaction
volume may also affect the DS of the sample. The effect of HClSO3 concen-
tration on the DS can be observed clearly in Table 3.1.1. The samples where
1.75 % to 2.75 % (v/v) HClSO3 were used in the sulfation mixture show
resulting DS varying between 0.27 for the lowest concentration of HClSO3
and up to 0.79 for the highest concentration of acid. The effect of solubility
of the alginate is clear from the various results obtained for the four batches
of alginate-sulfate produced using 3.5 % HClSO3 in the sulfation mixture,
where the acid concentration was the same for all batches. The use of a
freeze dried alginate in batch 2 and 3 gave a slowly dissolving alginate mix-
ture where the slow mixing in the solution is probably the cause of lower
degrees of sulfation (0.77 and 0.80) for these batches than the one observed
for batch 1 (0.90), where alginate in powder form was used. Batch 2 even
ended up with a lower DS than the sample where 2.75 % (v/v) HClSO3
was used. However, the reaction volumes also differed between batch 1 and
batch 2/3, and this may also have played a part in the resulting differences
in the DS of the samples. The sulfation of the sample of a molecular weight
45 kDa ended up with only a slightly higher DS than batch 2 and 3, even
though this sample seemed to dissolve rather quickly in the reaction mixture.
Acid hydrolysis revealed, as shown in Figure 3.2.1 and Table 3.2.2, a higher
depolymerization rate for the sulfated samples compared to the unmodified
alginate LF200S. The decrease in molecular weight of the two sulfated sam-
ples was similar, but as the sample of a higher DS has a higher molecular
weight per monosacchharide, the drop in average chain length is more rapid
for the highly sulfated sample. The calculated pseudo first order rate con-
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stants increase with the DS, from 0.017 min−1 for LF200S, via 0.039 min−1
for DS 0.27, to 0.050 min−1 for DS 0.90. These results agree with the results
found by Smidsrød et al. for dextran and dextran sulfate (Smidsrød et al.,
1966), and may be caused by a higher concentration of protons around the
polysaccharides with many negatively charged sulfate groups compared to
the bulk solution. It should be noted that the molecular weight of the sul-
fated samples may be underestimated, as the value of the refractive index,
dn
dc
used in the analysis is that of unmodified alginate. If alginate follows
the same trend as carrageenan from the experiments of Berth et al. (Berth
et al., 2008), the value of dn
dc
for sulfated samples should have been slightly
lower when more sulfate groups are added to the polysaccharides. The sul-
fate groups in the sulfated samples may not be evenly distributed along the
polysaccharide chain, as shown by Arlov et al. (Arlov et al., 2014), and some
parts of the chain may therefore be more susceptible to acid hydrolysis than
other parts. As the heterogeneity observed by Arlov et al. was especially
large for the less sulfated samples, this may especially be true for the sample
with a DS of 0.27, and the local variations within the sample may be greater
than for the highly sulfated sample.
Hydrolysis of LF200S was performed to produce a sample of similar average
molecular weight as the sulfated sample used in the gel strength experiments,
and a low molecular weight sample of 45 kDa for use in alginate microbeads,
as shown in Table 3.2.3. Although differences in the solubility and reaction
volume of alginate samples used to produce alginate of DS 0.90, DS 0.77 and
DS 0.80 affected the final degree of sulfation, it did not affect the depolymer-
ization of the samples during the sulfation process, as DS 0.90 and DS 0.77
have almost identical molecular weights. As the samples with DS 0.77 and
0.80 were produced under the same conditions, the difference in the molec-
ular weight of these two are probably due to random variations during the
sulfation process, or inaccurate measurements in the SEC-MALLS analysis.
Alginate-calcium gel beads made from alginate-sulfate were shown to have
a much lower osmotic stability in a physiological saline solution compared
to beads made of unmodified alginate, as observed in Figure 3.3.1 and Fig-
ure 3.3.2. The production of calcium-alginate beads using a sample with a
DS of 0.79 failed, as the alginate solution only formed plaques on the surface
of the gelling bath. The sample with a DS of 0.59 formed beads, but they
were highly unstable, with all beads gone after only three treatments with 0.9
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% NaCl, and a low tolerance for an increase in the volume of the beads. The
beads with a DS of only 0.27 was somewhat more stable, but lasted for only 7
treatments, showing that alginate-sulfate on its own is not a stable material
for use in physiological saline solutions. This is to be expected, as the charge
of the alginate-sulfate increases the number of counter-ions held back in the
beads, leading to a higher osmotic pressure inside the beads (Moe, 1993). In
addition, the bulky sulfate groups are probably contributing to a weaker gel
network as they disturb the ideal binding of ions described in the ”egg-box”
model (Grant et al., 1973).
Mixtures between alginate-sulfate (DS 0.90 or DS 0.68) and alginate LF200S
showed a general decrease in stability with increasing proportions of alginate-
sulfate. However, it appears that use of mixtures increase the stability of
the beads with respect to total sulfate content, compared to beads made
from only alginate-sulfate, as shown in Table 3.3.1. This is especially clear
when comparing the sample with DS 0.27 and the sample made from 40
% alginate-sulfate with DS 0.68 and 60 % LF200S, where the total sulfate
content of the beads corresponds to a DS of 0.27. Here, the beads made
from only alginate-sulfate were all gone after 7 treatments and the last re-
maining beads tolerated an increase in volume of about 110 %, as shown in
Figure 3.3.1 and Figure 3.3.2. In comparison, as showed in Figure 3.3.5 and
Figure 3.3.6, the last beads made from the mixed solution did not rupture
before after 13 treatments, and the increase in volume reached 200 %.
An exception to the general trend of decreasing stability with increasing
content of alginate-sulfate is observed in beads containing low proportions
of alginate-sulfate. Alginate/DS 0.90 beads containing 20 % DS 0.90, and
alginate/DS 0.68 beads with 20 - 40 % DS 0.68 show a slightly higher stabil-
ity than the beads made from only unsulfated alginate. Since the negative
charges of the sulfate groups is likely to contribute to a higher osmotic pres-
sure inside the beads, this stability is probably due to a strengthening of
the elastic reaction of the gel network (Moe, 1993). It is unknown how the
incorporation of few sulfate groups can give rise to more stable gel networks.
Use of 50 mM BaCl2 in the gelation bath of alginate/DS 0.90 beads to study
whether the relationship between the stability of 0 % beads and 20 % beads
was ion specific did not result in a clear answer of this question. As shown
in Figure 3.3.7, stable beads were formed for mixtures containing less than
60 % DS 0.90 alginate, making it hard to judge whether the 20 % beads
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were more stable than the 0 % beads for this ion. A lower concentration of
BaCl2 in the gelation bath should probably have been utilised in order to
study the differences between the mixtures of low content of alginate-sulfate.
Observing Figure 3.3.4 and Figure 3.3.8, the barium-alginate beads of a high
alginate-sulfate content seem to tolerate a somewhat lower increase in the
volume than the calcium-alginate beads.
The higher stability of the 20 % beads than the 0 % beads gelled in CaCl2 was
thought to be due to a higher ability to bind and retain calcium. However,
this hypothesis was proved wrong by the results from the elemental analysis
for calcium in the beads, as there was no observable difference in calcium con-
tent between the 0 % and 20 % beads neither after 0, 6 nor 13 measurements.
The 40 % beads seemed to have a slightly higher calcium content before the
first treatment with NaCl, but this difference was no longer observable after
6 treatments. The calcium content of the beads thereby show no sign of be-
ing the determining factor for the differences in bead stability between these
three samples. The elemental analysis also revealed a sulfate content of the
beads where the 40 % beads contained about double the amount of sulfur
as the 20 % beads, indicating that the alginate/alginate-sulfate ratio in the
solutions have been retained in the gels throughout the experiment. The
method used for the studies of swelling of alginate beads does not provide
very accurate measurements of diameters and hence volume of the beads,
but does still provide the means to to observe relative differences between
samples. As long as many beads are present in the sample, the error asso-
ciated with the measurement of the diameter of a single bead is kept quite
small, as the error in the reading is distributed over a larger number of beads.
The measurements of diameters for few beads have a larger error associated
with them, and the values of maximum increase in volume of the beads may
therefore not be very reliable.
The gel strength measurements showed a decrease in alginate gel strength
as the proportion of alginate-sulfate in the gel increased. As shown in Fig-
ure 3.4.1, the gels cover a wide range of gel strengths from an average Young’s
modulus of 310 kPa (135 kPa when corrected for syneresis) for the gels con-
taining only unsulfated alginate and down to only 26 kPa (16 kPa) for the
gels containing only alginate-sulfate. These gels cover the range of several
biological tissues, such as skeletal muscle and cardiac cells (Mathur et al.,
2001). Partially depolymerized alginate LF200S of a molecular weight simi-
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lar to the alginate-sulfate used in the mixtures was mixed with unmodified
alginate for a control experiment on the effect of molecular weight on E. Com-
parisons of these mixtures with the alginate/alginate-sulfate mixtures show,
in Figure 3.4.1, that the initial decrease, up to a content of alginate-sulfate
or hydrolysed alginate of about 10 % seems to be caused at least partially
by the lower molecular weight of the alginate-sulfate, which is at about 160
kDa, compared to about 280 kDa for unsulfated alginate. For a content
of alginate-sulfate of 20 % and higher, it appears that the lower molecular
weight is of less importance for the decrease in the Young’s modulus than
the content of sulfate groups in the gels. The drop caused by the addition of
sulfate groups may be due to steric hindrance and by electrostatic repulsion
between the negatively charged sulfate groups, interfering with the junction
formation in the gel. All the gels experienced some syneresis effects during
gelation, and the Young’s modulus was corrected for this effect according to
the new weight and concentration of the gels.
In contrast to the gel stability, Figure 3.4.2 reveals that strength of the
gels does not show any apparent improvement by mixing of alginate and
alginate-sulfate. This is showed by comparison between gels made from
alginate-sulfate and gels made from alginate/alginate-sulfate mixtures, where
the total sulfate content of the mixed gels is translated into an approximate
DS with respect to all the alginate in the gel. This may imply that the gel
strength is affected mostly by the total sulfate content of the gels rather than
by the distribution of these sulfate groups.
The calcium-alginate gel beads produced from mixtures of alginate and fluorescence-
labelled alginate-sulfate showed, as can be observed in Figure 3.5.2 and Fig-
ure 3.5.3, a clear gradient in the distribution of alginate-sulfate when the
beads were stored in the gelation solution or in a HEPES solution. This
is the same behaviour as observed for calcium-alginate beads produced by
other groups, with a higher alginate concentration at the bead surface than in
the core of the bead (Skj˚ak-Bræk et al., 1989). The gradient kept constant
throughout the two weeks of observation for the two samples. The beads
stored in CaCl2 experienced a dramatic drop in mechanical stability over the
two week period, observed by a drop in the number of beads in the solution,
as well as by more uneven surfaces for the remaining beads. It has been
shown by other groups that washing with NaCl leads to less heterogeneity
in microcapsules (Strand et al., 2003a). This effect also holds true for beads
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containing alginate-sulfate, as the alginate-sulfate, as shown in Figure 3.5.1,
is distributed evenly throughout the beads subjected to washing with, as
well as storage in, NaCl. These beads also kept their profiles through the
two weeks of observations. In order to observe whether the distribution of
alginate-sulfate differs in any way from the distribution of unsulfated alginate
in the beads, both the alginates should have been labelled with fluorescence
in two separate parts of the emission spectra. The molecular weight of the
two alginate would also have to be equal, as the heterogeneity in the beads
increases with lower molecular weights (Skj˚ak-Bræk et al., 1989).
Alginate-sulfate samples at 10 µg/ml in solution with DS 0.59 and DS 0.80
showed the ability to bind to FGF and inhibit its interaction with the sur-
face of RPMI-8226 cells compared to a control sample without alginate. As
shown in Figure 3.6.1, unsulfated alginate LF200S and alginate-sulfate with
a DS of 0.27 did not show the same ability. The highest sulfated sample
showed the highest degree of inhibition of FGF-cell surface interaction. For
mixtures consisting of alginate-sulfate (DS 0.80) and unsulfated LF200S, a
trend of increased binding to FGF with a higher content of alginate-sulfate
can be observed in Figure 3.6.2. For mixtures where 60 % or more of the
alginate was sulfated, an increase in the content of alginate-sulfate did not
affect the ability to inhibit cell-FGF interaction. Even the mixture with only
20 % alginate-sulfate showed some ability to bind to FGF, in contrast to the
sample consisting of only alginate-sulfate with a DS of 0.27. This may indi-
cate that a certain density of sulfate groups can promote binding to FGF,
and that this density is not reached for the DS 0.27 sample.
FGF was, as shown in Figure 3.6.3, released from all the gel disks made from
alginate/alginate-sulfate mixtures, with a seemingly greater release from the
gels during the first four days of the experiment. As the samples were not
diluted before the ELISA and the measured absorbances were all outside the
range of the standard, the concentrations of the solutions are not accurately
known. Hence the release profile from the gels could not be calculated, and
no exact comparisons between the gel disks can be made. From the solutions
of dissolved gel disks the results, given in Figure 3.6.4, show that almost no
FGF was left in the pure LF200S gel disks after 14 days, while there was still
FGF left in all the gel disks containing alginate-sulfate. Both the interaction
shown between FGF and alginate-sulfate in solution, and the pore size of the
gels, can affect the diffusion of FGF from the gel disks. Larger average pore
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size is correlated to weaker gel strength (Shoichet et al., 1996), and the gels
containing alginate-sulfate could thus be expected to have a larger average
pore size than the gels made from pure LF200S alginate. The interaction
between FGF and alginate-sulfate is expected to delay the outward diffusion
of FGF from the gel disks. The results showing that there was still some
FGF remaining in the gels containing alginate-sulfate, and not in pure algi-
nate gels, indicate that the interaction with FGF is the dominating factor
for diffusion rate in this system. These results correspond well to the re-
sults found by Freeman et al. for release of FGF from gel beads containing
alginate/alginate-sulfate mixtures (Freeman et al., 2008). As FGF is released
from all the gel disks initially, it might be that the initial average pore size
of all the gels are large enough to accommodate diffusion of FGF out of the
gels, and that a further increase in pore size is of no significant effect.
As gels from alginate/alginate-sulfate mixtures can obtain a higher stabil-
ity in physiological solutions as well as better ability to interact with FGF
than alginate-sulfate alone, mixtures are probably better suited for tissue
engineering applications than alginate-sulfate alone. The gels also have me-
chanical stabilities covering the range of several tissues, which is an advantage
for tissue engineering. Microcapsules made from mixtures are able to retain
the polymer gradient that is often desirable for microcapsules (Strand et al.,
2003a). In addition to varying the G/M ratio, molecular weight and de-
gree of sulfation on the alginate, use of different proportions of alginate and
alginate-sulfate in the gels can be used to tune the strength, stability and
biological activity of the gels, making the mixtures interesting candidates for
future use within tissue engineering applications.
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5. Future Directions
The FGF release studies should be repeated with dilution series in order to
acquire release profiles for the gel disks made from different alginate/alginate-
sulfate mixtures. When incorporating growth factors in hydrogel scaffolds,
the release rate should be controllable. If it turns out that the release profile
varies between different mixtures of alginate and alginate-sulfate, the pro-
portions in the mixture can be tuned to achieve the desired release rate or
profile from the hydrogel. The role of pore size on the diffusion rate from
the gels could be further investigated by diffusion studies using a macro-
molecule of about the same hydrodynamic volume as FGF, but without the
ability to interact with the alginate-sulfate of the gels. The difference in pore
sizes between gels made from different mixtures could be investigated by use
of electron microscopy or packing columns using macromolecular standards
(Gombotz and Wee, 2012b).
The stability of the gels made from mixtures should also be further investi-
gated. Especially the gels from mixtures of a low alginate-sulfate content are
interesting for further studies, as these have shown surprisingly high stability.
Use of alginate-sulfates with a wide range of DS could be used in the mix-
tures to study the effect of the sulfate distribution on the osmotic stability.
Subtoxic amounts of BaCl2 in the gelation bath, such as the 1 mM BaCl2,
50 mM CaCl2 solutions used by Mørch et al. (Mørch et al., 2012), may be
used to investigate whether these beads are still more stable than the pure
LF200S alginate beads when other ions than only calcium are involved in the
crosslinking. This could also contribute to a smaller increase in volume of the
beads, helping to maintain the original shape of beads or scaffolds. The bead
stability could also be studied in a medium with even higher resemblance to
a biological system.
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As the possibility of cell anchorage is a desired property of tissue engi-
neering scaffolds, cell adhesion and differentiation on hydrogels made from
alginate/alginate-sulfate mixtures should be studied. This could be done by
the method described by Rowley et al. for their investigation of peptide-
coupled hydrogels (Rowley et al., 1999a). This method involves seeding of
cells onto the hydrogels and the included controls, with cell counts and ob-
servations being carried out over time.
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6. Conclusions
Alginate was successfully sulfated using chlorosulfonic acid and formamide.
The degree of sulfation depended on the concentration of HClSO3 and the
solubility of the alginate. The sulfation process caused some depolymer-
ization of the alginate and led to a higher susceptibility to acid hydrolysis.
Beads made from alginate/alginate-sulfate mixtures had a higher osmotic
stability with respect to total sulfate content than beads made from pure
alginate-sulfate. A general decrease in stability for increasing sulfate content
was observed. However, beads containing small amounts of alginate-sulfate
obtained a higher stability than the beads made from unmodified alginate.
There was no observable difference in calcium content of the pure LF200S
beads and the beads containing small amounts of alginate-sulfate. The gel
strength of alginate/alginate-sulfate mixtures decreased with an increasing
proportion of alginate-sulfate in the gel, where the initial drop was probably
caused by the lower molecular weight of the alginate-sulfate. The distribu-
tion of alginate-sulfate in microbeads made of alginate/alginate-sulfate was
similar to the distribution in gels made from pure alginate. Alginate-sulfate
showed interactions with FGF in solution, and FGF was released gradually
from alginate/alginate-sulfate gel disks.
Use of mixtures between alginate and alginate-sulfate improves osmotic sta-
bility and FGF interactions, with no apparent effect on gel strength and
distribution in microbeads, and may be a better suited material for use in
tissue engineering than pure alginate-sulfate. The mixtures have gel strengths
covering the range of several tissues, can interact with FGF, and have tun-
able stability, making them interesting materials for future research on tissue
engineering scaffolds.
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Appendices
I

A. Risk Assessment
A risk assessment was conducted prior to the master project, to identify po-
tential hazards associated with the work in the biopolymer laboratory.
The risk assessment consists of two parts, the first being a list identifying
activities that should be assessed, along with already existing measures to
prevent damage, existing documentation on the matter and important addi-
tional information.
The second part is the actual risk assessment of the previous listed activ-
ities, including possible hazards, the probability for them to happen, the
severity and consequences of such an event, and measures that should be
taken to avoid such an episode. The combined values from the evaluation of
probability and consequences of an unwanted event, make up a risk value,
where different values come with different requirements for measures to be
taken.
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B. Calculation of the Degree of
Sulfation from Elemental
Analysis Data
The data from the elemental analysis using HR-ICP-MS are given as µg sulfurg sample ,
which can easily be converted to the weight fraction of sulfur (% S) in the
sample. To calculate the degree of sulfation (DS), the average number of
sulfate groups attached to each alginate monosaccharide, a standard curve
was constructed to give the relationship between % S and DS.
The standard curve was constructed by calculating % S for a range of theoret-
ical values of DS. The maximum theoretical value for DS is 2, corresponding
to the replacement of both the free hydroxyl groups of a monosaccharide in
the polymer chain with sulfur groups . An example calculation for DS = 1 is
given in Equation B.1 to B.6. For calculations of average molecular weight
of a monosaccharide it was assumed that one water molecule is associated
with each monosaccharide, and that a sodium ion is associated with each
carboxylgroup and sulfate group.
Mw = C6O6H5 +H2O + (1 +DS)×Na+ +DS × SO−3 (B.1)
Mw = 173 g/mol + 18 g/mol + (1 + 1)× 23 g/mol + 1× 80 g/mol (B.2)
Mw = 317 g/mol (B.3)
XI
%S = DS ×MS
Mw
× 100% (B.4)
%S = 1× 32 g/mol317 g/mol × 100% (B.5)
%S = 10.1% (B.6)
The calculated values for the standard curve are all given in Table B.1.
Table B.1: The calculated values of % S for theoretical DS values in
the range 0 to 2, used in the standard curve.
DS Mw % S
2.00 420.0 15.2
1.75 394.3 14.2
1.50 368.5 13.0
1.25 342.8 11.7
1.00 317.0 10.1
0.75 291.3 8.2
0.50 265.5 6.0
0.25 239.8 3.3
0.00 214.0 0.0
Using the values from Table B.1, the standard curve was constructed by plot-
ting % S as a function of DS. A second degree polynomial was fitted to the
curve, as shown in Figure B.1. The second degree polynomial allows for the
calculation of an approximate value of DS when the % S is known.
XII
Figure B.1: The standard curve for the relationship between % S and the
degree of sulfation (DS), constructed from the values in Table B.1. A second
order polynomial is fitted to the curve, with the formula shown in the figure.
The DS can thus be calculated from the % S values from the elemental
analysis by use of the formula given in Equation B.7.
DS = −12.824 +
√
12.8242 − 4× 2.6627×%S
−2× 2.6627 (B.7)
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C. The Young’s Modulus of
Gels Made from Sulfated
Alginate of Varying DS
From earlier work on my specialization project at the Department of Biotech-
nology, NTNU, the Young’s moduli of samples containing only sulfated algi-
nate with different degrees of sulfation have been calculated. These results
were used to compare the effect of using mixtures instead of homogeneous
samples on the gel strength.
This Appendix contains the calculated Young’s modulus for each sample of
a different DS, both before and after correction for syneresis, along with the
standard deviation and the coefficient of variation for the corrected Young’s
modulus, all given in Table C.1.
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Table C.1: The calculated Young’s modulus for samples of alginate-
sulfate with varying DS, both before and after correction for
syneresis (E and Ecorr respectively), along with the standard devi-
ation (std) and the coefficient of variation (CoV) for the corrected
Young’s modulus. All results are from the specialization project.
DS E [kPa] Ecorr[kPa]
stdEcorr
[kPa] CoV
0.01 232 100 9 0.09
0.27 135 62 6 0.10
0.59 72 38 4 0.11
0.66 44 26 4 0.14
0.68 64 38 7 0.20
0.86 35 20 4 0.19
0.90 25 16 4 0.24
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D. Calculating the Pseudo First
Order Rate Constant of Acid
Hydrolysis
Sulfated alginate samples of DS 0.27 and DS 0.90 were together with an un-
modified sample of alginate LF200S subjected to acid hydrolysis in a time
series. The calculated weight average molecular weights of the samples from
analysis using SEC-MALLS were used to find the pseudo first order rate con-
stant.
For the calculations, the molecular weights of the single monosaccharides,
M0 in each sample were required. They were calculated as shown in Equa-
tion D.1 and Equation D.2, assuming one sodium ion associated with each
monomer, and an extra ion for each sulfate group on the monomer.
M0 = C6O6H7 + SO3 ×DS +Na+ × (1 +DS) (D.1)
175 g
mol
+ 80 g
mol
×DS + 23 g
mol
× (1 +DS) (D.2)
The calculated values of M0 for each sample are given in Section 3.2.1.
Table D.1 shows the calculated values of 1
Mw
and the degree of polymeri-
sation, DPw for the sample of unmodified alginate. The same results for the
sulfated samples are shown in Table D.2 and Table D.3.
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Table D.1: The weight average molecular weights of the unmodified
alginate sample after acid hydrolysis for a time series, along with
the calculated value of 1
Mw
and the degree of polymerisation, DPw.
LF200S
Time [min] Mw [kDa] 1Mw DPw
0 284 3.5E-03 1326
10 229 4.4E-03 1072
20 204 4.9E-03 953
30 196 5.1E-03 917
50 157 6.4E-03 735
100 114 8.7E-03 534
150 93 1.1E-02 434
200 81 1.2E-02 380
Table D.2: The weight average molecular weights of the sulfated al-
ginate sample with DS 0.27 after acid hydrolysis for a time series,
along with the calculated value of 1
Mw
and the degree of polymeri-
sation, DPw.
DS 0.27
Time [min] Mw [kDa] 1Mw DPw
0 159 6.3E-03 658
10 152 6.6E-03 629
20 135 7.4E-03 558
30 127 7.9E-03 525
50 95 1.1E-02 393
100 68 1.5E-02 281
150 53 1.9E-02 219
200 44 2.3E-02 182
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Table D.3: The weight average molecular weights of the sulfated al-
ginate sample with DS 0.90 after acid hydrolysis for a time series,
along with the calculated value of 1
Mw
and the degree of polymeri-
sation, DPw.
DS 0.90
Time [min] Mw [kDa] 1Mw DPw
0 161 6.2E-03 525
10 139 7.2E-03 453
20 131 7.6E-03 427
30 109 9.2E-03 355
50 92 1.1E-02 300
100 67 1.5E-02 218
150 50 2.0E-02 163
200 44 2.3E-02 143
The plot of 1
Mw
against time is sown in Figure 3.2.1 in Section 3.2.1.
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E. Data From the Swelling of
Alginate Beads in NaCl
E.1 Sulfated Alginate Samples
Alginate gel beads were made by use of external gelation with 50 mM CaCl2
for sulfated alginate samples of DS 0.27, DS 0.59, DS 0.79 and unmodified
alginate LF200S. The beads were submitted to treatments with 18 ml 0.9
% (w/v) NaCl every hour. The number of beads and the average diameter
for the beads of each sample were measured between every treatment. This
Appendix contains the measured number of beads, average diameter and av-
erage increase in volume for the beads between every treatment with 0.9 %
(w/v) NaCl.
The number of beads made from different alginate samples at every mea-
surement point is shown in Table E.1.1. The average diameter of the beads
can be found in Table E.1.2, while the average increase in volume over time
is found in Table E.1.3.
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Table E.1.1: The number of beads made from samples of alginate of
different DS after subsequent 1 hour treatments with 0.9 % NaCl.
Number of Alginate Beads
Number of
Treatments LF200S DS 0.27 DS 0.59
0 53 53 53
1 53 53 49
2 53 53 20
3 53 53 0
4 52 44 0
5 52 24 0
6 52 9 0
7 50 0 0
Table E.1.2: The average diameter of beads made from samples of
alginate of different DS after subsequent 1 hour treatments with
0.9 % NaCl.
Average Diameter of Alginate Beads [mm]
Number of
Treatments LF200S DS 0.27 DS 0.59
0 3.49 3.55 3.21
1 3.51 3.57 3.20
2 3.57 3.71 3.70
3 3.74 3.92
4 3.92 4.09
5 4.06 4.42
6 4.10 4.56
7 4.64
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Table E.1.3: The average increase in volume of beads made from
samples of alginate of different DS after subsequent 1 hour treat-
ments with 0.9 % NaCl.
Relative Increase in Volume [%]
Number of
treatments LF200S DS 0.27 DS 0.59
0 0 0 0
1 2 2 -1
2 7 14 53
3 23 35
4 42 53
5 57 93
6 62 112
7 135
A graphical representation of the number and the average increase in volume
as a function of the number of treatments can be found in Figure 3.3.1 and
Figure 3.3.2 in Section 3.3.1.
E.2 Alginate/Alginate-Sulfate Mixtures, CaCl2
Alginate gel beads were made by use of external gelation with 50 mM CaCl2
for mixtures of sulfated alginate of DS 0.68 or DS 0.90 with unmodified
alginate LF200S. The beads were submitted to treatments with 18 ml 0.9
% (w/v) NaCl every hour. The number of beads and the average diameter
for the beads of each sample were measured between every treatment. This
Appendix contains the measured number of beads, average diameter and
average increase in volume for the beads between every treatment with 0.9
% (w/v) NaCl.
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Alginate/Alginate-Sulfate Mixtures using a DS 0.90 Alginate
The number of Ca-alginate beads made from DS 0.90/LF200S mixtures at
different proportions, at every measurement point is shown in Table E.2.1.
The average diameter of the beads can be found in Table E.2.2, while the
average increase in volume over time is found in Table E.2.3.
Table E.2.1: The number of Ca-alginate beads made from alginate
DS 0.90/LF200S mixtures after each treatment with 0.9 % NaCl.
Number of Alginate Beads
Number of
Measurements 0 % 20 % 40 % 60 % 80 %
0 50 50 50 50 50
1 50 50 50 50 50
2 50 50 50 50 42
3 50 50 50 49 28
4 50 50 49 46 8
5 50 50 47 33 1
6 50 50 47 28 0
7 50 50 39 17
8 48 50 31 6
9 40 49 14 0
10 27 49 7
11 10 45 1
12 5 42 0
13 0 37
14 7
15 3
16 0
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Table E.2.2: The average diameter of Ca-alginate beads made from
alginate DS 0.90/LF200S mixtures after each treatment with 0.9
% NaCl.
Average Diameter of Alginate Beads [mm]
Number of
Treatments 0 % 20 % 40 % 60 % 80 %
0 3.82 3.94 3.38 3.60 3.26
1 3.76 3.84 3.42 3.56 3.40
2 3.84 3.90 3.58 3.72 3.62
3 4.04 4.04 3.72 4.00 3.93
4 4.22 4.18 3.88 4.15 4.25
5 4.32 4.34 4.00 4.45
6 4.56 4.36 4.15 4.43
7 4.60 4.52 4.26 5.35
8 4.73 4.60 4.42 5.33
9 5.13 4.80 4.64
10 5.11 4.90 5.29
11 5.30 4.93 5.50
12 5.40 4.95
13 5.05
14 5.57
15 5.67
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Table E.2.3: The average increase in volume of Ca-alginate beads
made from alginate DS 0.90/LF200S mixtures after each treatment
with 0.9 % NaCl.
Relative Increase in Volume of Alginate Beads [%]
Number of
Treatments 0 % 20 % 40 % 60 % 80 %
0 0 0 0 0 0
1 -5 -7 4 -3 13
2 2 -3 19 10 37
3 18 8 33 37 75
4 35 19 51 53 122
5 45 34 66 89 261
6 70 36 85 86
7 75 51 100 229
8 90 59 124 225
9 141 80 159
10 140 92 282
11 167 96 331
12 182 99
13 111
14 183
15 198
A graphical representation of the number and the average increase in volume
as a function of the number of treatments can be found in Figure 3.3.3 and
Figure 3.3.4 in Section 3.3.2.
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Alginate/Alginate-Sulfate Mixtures using a DS 0.68 Alginate
The number of beads made from DS 0.68/LF200S mixtures at different pro-
portions, at every measurement point is shown in Table E.2.4. The average
diameter of the beads can be found in Table E.2.5, while the average increase
in volume over time is found in Table E.2.6.
Table E.2.4: The number of Ca-alginate beads made from alginate
DS 0.68/LF200S mixtures after each treatment with 0.9 % NaCl.
Number of Alginate Beads
Number of
Treatments 0 % 20 % 40 % 60 % 80 % 100 %
0 50 50 50 50 50 50
1 50 50 50 50 50 42
2 50 50 50 50 50 9
3 50 50 50 50 50 0
4 50 50 50 50 40 0
5 50 50 50 50 15 0
6 50 50 50 50 3 0
7 46 50 50 50 0 0
8 45 50 50 45 0 0
9 42 50 49 30 0 0
10 31 47 47 16 0 0
11 8 45 40 5 0 0
12 0 33 20 0 0 0
13 0 8 0 0 0 0
14 0 4 0 0 0 0
15 0 0 0 0 0 0
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Table E.2.5: The average diameter of Ca-alginate beads made from
alginate DS 0.68/LF200S mixtures after each treatment with 0.9
% NaCl.
Average Diameter of Alginate Beads [mm]
Number of
Treatments 0 % 20 % 40 % 60 % 80 % 100 %
0 3.64 3.48 3.54 3.64 3.52 2.96
1 3.64 3.5 3.54 3.68 3.58 3.29
2 3.74 3.58 3.64 3.76 3.84 3.67
3 3.86 3.74 3.78 3.96 4.06
4 4.02 3.88 3.92 4.14 4.30
5 4.12 4.02 4.06 4.28 4.93
6 4.30 4.06 4.2 4.52 5.33
7 4.48 4.22 4.34 4.56
8 4.56 4.30 4.50 4.69
9 4.64 4.40 4.45 4.73
10 4.71 4.45 4.57 5.19
11 5.13 4.56 4.65 5.20
12 4.85 5.1
13 5.13
14 5.75
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Table E.2.6: The average increase in volume of Ca-alginate beads
made from alginate DS 0.68/LF200S mixtures after each treatment
with 0.9 % NaCl.
Relative Increase in Volume of Alginate Beads [%]
Treatment
number 0 % 20 % 40 % 60 % 80 % 100 %
0 0 0 0 0 0 0
1 0 2 0 3 5 37
2 8 9 9 10 30 90
3 19 24 22 29 53
4 35 39 36 47 82
5 45 54 51 63 175
6 65 59 67 91 248
7 86 78 84 97
8 96 89 105 114
9 108 102 99 120
10 117 109 116 189
11 179 124 127
12 170 199
13 219
14 351
A graphical representation of the number and the average increase in volume
as a function of the number of treatments can be found in Figure 3.3.5 and
Figure 3.3.6 in Section 3.3.2.
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E.3 Beads from Alginate/Alginate-Sulfate Mix-
tures Gelled with BaCl2
To investigate whether gelation with BaCl2 would give the same results with
respect to the 0 % sample and the 20 % sample for the DS 0.90/LF200S
beads as gelation with CaCl2, the experiment was repeated using 50 mM
BaCl2 in the gelation bath. The data from this experiment are given below.
The number of beads from each sample of DS 0.90/LF200S mixtures, counted
between every measurement is shown in Table E.3.1. The measured average
diameter of the beads and the average increase in volume of the beads are
given in Table E.3.2 and Table E.3.3.
Table E.3.1: The number of Ba-alginate beads made from alginate
DS 0.90/LF200S mixtures after each treatment with 0.9 % NaCl.
Average Increase in Diameter of Ba-Alginate Beads [%]
Treatment
Number 0 % 20 % 40 % 60 % 80 % 100 %
0 50 50 50 50 50 50
1 50 50 50 50 50 50
2 50 50 50 50 50 50
3 50 50 50 50 50 48
4 50 50 50 50 50 48
5 50 50 50 50 50 48
6 50 50 50 50 49 47
7 50 50 50 50 49 47
8 50 50 50 50 49 45
9 50 50 50 50 49 44
10 50 50 50 50 49 44
11 50 50 50 50 49 40
12 50 50 50 50 49 28
13 50 50 50 50 49 21
14 50 50 50 50 49 2
15 50 50 50 50 49 1
Continued on next page
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Table E.3.1 – continued from previous page
Relative Increase in Volume of Ba-Alginate Beads [%]
Treatment
Number 0 % 20 % 40 % 60 % 80 % 100 %
16 50 50 50 50 49 0
17 50 50 50 50 42 0
18 50 50 50 50 33 0
19 50 50 50 50 28 0
20 50 50 50 50 13 0
21 50 50 50 50 8 0
22 50 50 50 50 6 0
23 50 50 50 50 5 0
24 50 50 50 50 1 0
25 50 50 50 50 0 0
26 50 50 50 47 0 0
27 50 50 50 46 0 0
28 50 50 50 45 0 0
29 50 50 50 45 0 0
30 50 50 50 40 0 0
31 50 50 50 38 0 0
32 50 50 50 38 0 0
33 50 50 50 37 0 0
34 50 50 50 32 0 0
35 50 50 50 30 0 0
36 50 50 50 28 0 0
37 50 50 50 25 0 0
38 50 50 50 21 0 0
39 50 50 50 19 0 0
40 50 50 50 11 0 0
41 50 50 50 11 0 0
42 50 50 50 4 0 0
43 50 50 50 2 0 0
44 50 50 50 1 0 0
45 50 50 50 0 0 0
46 50 50 50 0 0 0
Continued on next page
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Table E.3.1 – continued from previous page
Relative Increase in Volume of Ba-Alginate Beads [%]
Treatment
Number 0 % 20 % 40 % 60 % 80 % 100 %
47 50 50 50 0 0 0
48 50 50 49 0 0 0
49 50 50 49 0 0 0
50 50 49 48 0 0 0
51 50 49 47 0 0 0
52 50 49 47 0 0 0
53 50 49 47 0 0 0
54 50 49 47 0 0 0
55 50 48 47 0 0 0
56 50 48 47 0 0 0
57 50 48 47 0 0 0
58 50 48 47 0 0 0
59 50 48 47 0 0 0
60 50 48 47 0 0 0
61 50 48 47 0 0 0
62 50 48 47 0 0 0
63 50 48 47 0 0 0
64 50 48 47 0 0 0
65 50 48 47 0 0 0
Table E.3.2: The average diameter of Ba-alginate beads made from
DS 0.90/LF200S mixtures after each treatment with 0.9 % NaCl.
Average Increase in Diameter of Ba-Alginate Beads [%]
Treatment
Number 0 % 20 % 40 % 60 % 80 % 100 %
0 3.74 3.74 3.88 3.76 3.72 3.92
1 3.74 3.70 3.80 3.76 3.70 3.92
2 3.68 3.70 3.80 3.76 3.66 3.86
Continued on next page
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Table E.3.2 – continued from previous page
Relative Increase in Volume of Ba-Alginate Beads [%]
Treatment
Number 0 % 20 % 40 % 60 % 80 % 100 %
3 3.68 3.70 3.78 3.78 3.62 3.83
4 3.68 3.68 3.76 3.74 3.66 3.86
5 3.70 3.70 3.76 3.84 3.70 3.83
6 3.76 3.76 3.84 3.84 3.73 3.85
7 3.78 3.80 3.88 3.86 3.78 3.87
8 3.80 3.80 3.86 3.86 3.78 3.93
9 3.88 3.80 3.86 3.92 3.88 3.95
10 3.90 3.84 3.92 3.92 3.88 4.09
11 3.90 3.86 3.92 3.94 3.88 4.13
12 3.90 3.86 3.92 3.94 3.98 4.14
13 3.90 3.86 3.92 3.94 3.98 4.33
14 3.92 3.86 3.96 3.96 3.98 4.50
15 3.92 3.88 3.98 3.98 4.00 5.00
16 3.94 3.90 4.00 4.02 4.08
17 3.96 3.90 4.00 4.02 4.12
18 3.96 3.92 4.00 4.12 4.09
19 3.96 3.92 4.02 4.12 4.14
20 3.98 3.94 4.04 4.12 4.38
21 4.00 3.96 4.08 4.18 4.50
22 4.02 3.96 4.08 4.20 4.67
23 4.06 4.02 4.10 4.32 4.80
24 4.08 4.04 4.14 4.30 5.00
25 4.10 4.04 4.14 4.32
26 4.10 4.06 4.16 4.32
27 4.12 4.08 4.26 4.37
28 4.14 4.12 4.26 4.42
29 4.14 4.12 4.26 4.42
30 4.14 4.12 4.26 4.40
31 4.14 4.12 4.26 4.42
32 4.14 4.12 4.26 4.42
33 4.14 4.12 4.26 4.43
Continued on next page
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Table E.3.2 – continued from previous page
Relative Increase in Volume of Ba-Alginate Beads [%]
Treatment
Number 0 % 20 % 40 % 60 % 80 % 100 %
34 4.14 4.12 4.26 4.41
35 4.14 4.12 4.32 4.43
36 4.14 4.12 4.28 4.46
37 4.14 4.08 4.32 4.52
38 4.14 4.12 4.32 4.48
39 4.12 4.1 4.32 4.63
40 4.12 4.10 4.32 4.64
41 4.12 4.12 4.32 4.64
42 4.14 4.10 4.32 4.75
43 4.14 4.12 4.36 5.00
44 4.14 4.12 4.36 5.00
45 4.12 4.10 4.40
46 4.12 4.12 4.40
47 4.14 4.12 4.40
48 4.14 4.12 4.41
49 4.16 4.14 4.41
50 4.16 4.16 4.42
51 4.16 4.18 4.43
52 4.14 4.16 4.43
53 4.14 4.16 4.43
54 4.14 4.10 4.43
55 4.14 4.19 4.43
56 4.16 4.21 4.43
57 4.18 4.21 4.43
58 4.16 4.19 4.43
59 4.16 4.21 4.43
60 4.16 4.21 4.43
61 4.16 4.19 4.43
62 4.16 4.21 4.43
63 4.18 4.19 4.45
64 4.18 4.19 4.43
Continued on next page
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Table E.3.2 – continued from previous page
Relative Increase in Volume of Ba-Alginate Beads [%]
Treatment
Number 0 % 20 % 40 % 60 % 80 % 100 %
65 4.16 4.19 4.43
Table E.3.3: The average increase in volume of Ba-alginate beads
made from DS 0.90/LF200S mixtures after each treatment with
0.9 % NaCl.
Relative Increase in Volume of Ba-Alginate Beads [%]
Treatment
Number 0 % 20 % 40 % 60 % 80 % 100 %
0 0 0 0 0 0 0
1 0 -3 -6 0 -2 0
2 -5 -3 -6 0 -5 -5
3 -5 -3 -8 2 -8 -6
4 -5 -5 -9 -2 -5 -5
5 -3 -3 -9 7 -2 -6
6 2 2 -3 7 1 -5
7 3 5 0 8 5 -4
8 5 5 -2 8 5 1
9 12 5 -2 13 13 3
10 13 8 3 13 13 14
11 13 10 3 15 13 17
12 13 10 3 15 22 18
13 13 10 3 15 22 35
14 15 10 6 17 22 51
15 15 12 8 19 24 108
16 17 13 10 22 32
17 19 13 10 22 36
18 19 15 10 32 33
19 19 15 11 32 38
Continued on next page
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Table E.3.3 – continued from previous page
Relative Increase in Volume of Ba-Alginate Beads [%]
Treatment
Number 0 % 20 % 40 % 60 % 80 % 100 %
20 21 17 13 32 64
21 22 19 16 37 77
22 24 19 16 39 97
23 28 24 18 52 115
24 30 26 21 50 143
25 32 26 21 52
26 32 28 23 52
27 34 30 32 57
28 36 34 32 63
29 36 34 32 63
30 36 34 32 60
31 36 34 32 63
32 36 34 32 63
33 36 34 32 64
34 36 34 32 61
35 36 34 38 64
36 36 34 34 67
37 36 30 38 74
38 36 34 38 69
39 34 32 38 87
40 34 32 38 87
41 34 34 38 87
42 36 32 38 102
43 36 34 42 135
44 36 34 42 135
45 34 32 46
46 34 34 46
47 36 34 46
48 36 34 47
49 38 36 47
50 38 38 47
Continued on next page
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Table E.3.3 – continued from previous page
Relative Increase in Volume of Ba-Alginate Beads [%]
Treatment
Number 0 % 20 % 40 % 60 % 80 % 100 %
51 38 40 48
52 36 38 48
53 36 38 48
54 36 32 48
55 36 40 48
56 38 42 48
57 40 42 48
58 38 40 48
59 38 42 48
60 38 42 48
61 38 40 48
62 38 42 48
63 40 40 51
64 40 40 48
65 38 40 48
Graphical representations of the number of beads and the relative increase
in volume is given in Figure 3.3.7 and Figure 3.3.8 in Section 3.3.3.
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F. Data from the Longitudinal
Compression Test of Gels
This Appendix contains the data acquired from the longitudinal compres-
sion test conducted on alginate gels made from different mixtures of sulfated
or partially hydrolysed alginate with unmodified alginate LF200S. The data
includes the initial slope obtained from the area of the force-distance plot
between 0.4 and 0.5 mm of compression, the measured diameter, height and
weight of the gels, and the calculated cross-sectional surface area of the gels.
The force-distance plots for the six gels from the 10 % DS 0.77/LF200S
sample are shown in Figure F.1. The two red vertical lines mark the dis-
tance between 0.4 and 0.5 mm, used to find the initial slope of each curve.
The linear regression lines from this area of the graph are shown in red.
The data for the mixtures between sulfated alginate with a DS of 0.77 and
unmodified alginate LF200S in different proportions to each other, are given
in Table F.1 to Table F.8. Table F.9, Table F.10 and Table F.11 contain the
data for gels made from mixtures between partially hydrolysed alginate and
unmodified alginate LF200S.
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Figure F.1: The force-distance plots for the six gels from the 10 % DS
0.77/LF200S sample, where the red lines are the regression lines fitted to
the graphs in the area marked by the two red vertical lines.
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Table F.1: The weight of the gels from the 0 % sample of DS
0.77/LF200S before and after syneresis, the measured slope of the
initial force-distance plot in the longitudinal compression test, the
measured diameter and height of the gels, and the calculated cross-
sectional surface area of the gels.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 2.04 11.41 14.40 102 2.31 1.50
2 2.40 11.27 14.20 100 2.31 1.52
3 2.13 11.23 14.86 99 2.31 1.49
4 2.12 12.12 14.90 115 2.31 1.56
5 2.08 11.49 14.30 104 2.31 1.52
6 2.47 11.54 14.80 105 2.31 1.57
Average 2.21 11.51 14.58 104 2.31 1.53
St.dev 0.18 0.32 0.31 6 0 0.03
Table F.2: The weight of the gels from the 5 % sample of DS
0.77/LF200S before and after syneresis, the measured slope of the
initial force-distance plot in the longitudinal compression test, the
measured diameter and height of the gels, and the calculated cross-
sectional surface area of the gels.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 2.34 11.40 14.88 102 2.31 1.46
2 1.60 11.00 14.42 95 2.31 1.42
3 2.01 11.09 14.20 97 2.31 1.45
4 2.12 11.20 14.21 99 2.31 1.43
5 1.98 11.24 14.72 99 2.31 1.44
6 1.83 11.30 14.00 100 2.31 1.41
Average 1.98 11.21 14.41 99 2.31 1.44
St.dev 0.25 0.14 0.34 3 0.00 0.02
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Table F.3: The weight of the gels from the 10 % sample of DS
0.77/LF200S before and after syneresis, the measured slope of the
initial force-distance plot in the longitudinal compression test, the
measured diameter and height of the gels, and the calculated cross-
sectional surface area of the gels. One of the specimens of the
sample was omitted from the calculations as the slope was not
linear in the area between 0.4 and 0.5 mm of compression.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 1.54 11.75 14.42 108 2.31 1.38
2 1.47 11.12 14.32 97 2.31 1.34
3 1.69 11.25 14.22 99 2.31 1.35
4 1.57 11.13 14.74 97 2.31 1.36
5 1.78 11.34 13.99 101 2.31 1.37
Average 1.61 11.32 14.34 101 2.31 1.36
St.dev 0.12 0.26 0.28 5 0.00 0.02
Table F.4: The weight of the gels from the 20 % sample of DS
0.77/LF200S before and after syneresis, the measured slope of the
initial force-distance plot in the longitudinal compression test, the
measured diameter and height of the gels, and the calculated cross-
sectional surface area of the gels.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 1.78 11.05 13.91 96 2.31 1.39
2 1.33 11.66 14.20 107 2.31 1.42
3 1.44 11.02 14.51 95 2.31 1.39
4 1.32 11.15 14.18 98 2.31 1.42
5 1.51 11.14 14.07 97 2.31 1.37
6 1.49 10.84 14.22 92 2.31 1.36
Average 1.48 11.14 14.18 98 2.31 1.39
St.dev 0.17 0.28 0.20 5 0.00 0.02
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Table F.5: The weight of the gels from the 40 % sample of DS
0.77/LF200S before and after syneresis, the measured slope of the
initial force-distance plot in the longitudinal compression test, the
measured diameter and height of the gels, and the calculated cross-
sectional surface area of the gels.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 1.48 11.39 14.86 102 2.31 1.43
2 1.00 11.05 14.32 96 2.31 1.36
3 1.71 11.74 14.26 108 2.31 1.34
4 1.68 11.93 13.98 94 2.31 1.30
5 1.27 11.32 14.40 101 2.31 1.35
6 1.39 11.01 14.27 95 2.31 1.37
Average 1.42 11.24 14.35 99 2.31 1.36
St.dev 0.27 0.30 0.29 5 0 0.04
Table F.6: The weight of the gels from the 60 % sample of DS
0.77/LF200S before and after syneresis, the measured slope of the
initial force-distance plot in the longitudinal compression test, the
measured diameter and height of the gels, and the calculated cross-
sectional surface area of the gels. One of the specimens of the
sample was omitted from the calculations as the slope was not
linear in the area between 0.4 and 0.5 mm of compression.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 1.14 11.39 14.30 102 2.31 1.51
2 1.19 11.50 14.35 104 2.31 1.47
3 0.88 11.51 14.26 104 2.31 1.43
4 1.15 11.55 14.40 105 2.31 1.54
5 0.98 11.23 14.28 99 2.31 1.35
Average 1.07 11.44 14.35 103 2.31 1.46
St.dev 0.13 0.13 0.29 2 0 0.07
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Table F.7: The weight of the gels from the 80 % sample of DS
0.77/LF200S before and after syneresis, the measured slope of the
initial force-distance plot in the longitudinal compression test, the
measured diameter and height of the gels, and the calculated cross-
sectional surface area of the gels. One of the specimens of the
sample was omitted from the calculations as the slope was not
linear in the area between 0.4 and 0.5 mm of compression.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 0.61 11.59 14.17 106 2.31 1.65
2 0.56 11.59 14.54 106 2.31 1.63
3 0.67 12.03 14.62 114 2.31 1.72
4 0.66 11.80 14.07 109 2.31 1.70
5 0.62 11.87 14.29 111 0 1.68
Average 0.62 11.78 14.34 109 2.31 1.68
St.dev 0.04 0.19 0.24 4 0 0.04
Table F.8: The weight of the gels from the 100 % sample of DS
0.77/LF200S before and after syneresis, the measured slope of the
initial force-distance plot in the longitudinal compression test, the
measured diameter and height of the gels, and the calculated cross-
sectional surface area of the gels.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 0.25 12.62 14.36 125 2.31 1.87
2 0.11 12.28 14.65 118 2.31 1.82
3 0.21 12.01 13.99 113 2.31 1.70
4 0.16 12.70 14.56 127 2.31 1.81
5 0.27 12.37 14.36 120 2.31 1.86
6 0.28 12.25 14.76 118 2.31 1.82
Average 0.21 12.37 14.45 120 2.31 1.81
St.dev 0.07 0.25 0.27 5 0 0.06
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Table F.9: The weight of the gels from the 10 % sample of par-
tially hydrolysed alginate/LF200S before and after syneresis, the
measured slope of the initial force-distance plot in the longitudinal
compression test, the measured diameter and height of the gels,
and the calculated cross-sectional surface area of the gels.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 1.63 11.37 13.65 102 2.31 1.44
2 1.62 11.40 14.76 102 2.31 1.52
3 1.85 11.09 14.22 97 2.31 1.51
4 1.25 11.09 14.85 97 2.31 1.47
5 1.49 11.03 14.83 96 2.31 1.49
6 1.40 10.96 14.83 94 2.31 1.50
Average 1.54 11.16 14.52 98 2.31 1.49
St.dev 0.21 0.18 0.49 3 0 0.03
Table F.10: The weight of the gels from the 20 % sample of par-
tially hydrolysed alginate/LF200S before and after syneresis, the
measured slope of the initial force-distance plot in the longitudi-
nal compression test, the measured diameter and height, and the
calculated cross-sectional surface area of the gels. One of the spec-
imens of the sample was omitted from the calculations as the slope
was not linear in the area between 0.4 and 0.5 mm of compression.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 1.71 11.06 14.38 96 2.31 1.48
2 1.72 10.68 14.00 90 2.31 1.48
3 1.96 11.13 13.52 97 2.31 1.47
4 1.70 11.05 14.36 96 2.31 1.52
5 1.62 11.06 14.12 96 2.31 1.45
Average 1.74 11.00 14.08 95 2.31 1.48
St.dev 0.13 0.18 0.35 3 0 0.03
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Table F.11: The weight of the gels from the 60 % sample of par-
tially hydrolysed alginate/LF200S before and after syneresis, the
measured slope of the initial force-distance plot in the longitudinal
compression test, the measured diameter and height of the gels,
and the calculated cross-sectional surface area of the gels.
Weight of Gel [g]
Gel
Num-
ber
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Synere-
sis
After
Synere-
sis
1 1.98 11.28 14.35 100 2.31 1.51
2 2.09 11.32 14.40 101 2.31 1.61
3 1.81 11.74 14.84 108 2.31 1.60
4 1.77 11.32 14.32 101 2.31 1.42
5 1.29 11.40 14.92 102 2.31 1.52
6 1.66 11.57 14.74 105 2.31 1.50
Average 1.77 11.44 14.60 103 2.31 1.53
St.dev 0.28 0.18 0.27 3 0 0.07
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G. Calculations of the Young’s
Modulus
Gels made from DS 0.77/LF200S mixtures were subjected to a longitudinal
compression test, and the Young’s modulus calculated from the initial slope
of the force-distance plot obtained from this test. This Appendix contains
the calculation of the Young’s modulus of the first gel from the sample 5 %,
where 5 % (w/w) of the total alginate content is alginate with a DS of 0.77,
along with the correction for syneresis of the gel.
The slope from the initial force-distance plot from the compression test,
along with the diameter, height and weight of each of the gels from the 5 %
sample can be found in Table F.2 in Appendix F, with a summary of the
values of the first gel given in Table G.1.
Table G.1: The values of weight, slope of the initial force-distance
plot in the longitudinal compression test, diameter, height and
cross-sectional surface area of the first gel from the 5 % sample of
DS 0.77/LF200S.
Weight of Gel [g]
Slope
[N/mm] d [mm] h[mm]
a
[mm2]
Before
Syneresis
After
Syneresis
2.34 11.40 14.88 102 2.31 1.46
The Young’s modulus can be calculated according to Equation 1.4.1 in Sec-
tion 1.4 when the slope of the initial force-deformation curve, the cross-
sectional area of the gel, and the initial length or height of the gel is known.
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For the 5 % sample of DS 0.77/LF200S mixtures, this gives the Young’s
modulus shown in Equation G.1.
E = F∆l ×
l
A
= 2.34 N
mm
× 14.88mm102mm2 × 10
6 mm
2
m2
≈ 341 kPa (G.1)
As the weight of the gel has decreased from the gel was made and until the
gel measurements were conducted 24 h later, the Young’s modulus can be
corrected for syneresis according to Equation 1.4.2 in Section 1.4. For the
first of the 5 % gels this gives the result shown in Equation G.2.
Ecorrected = Emeasured ×
(
wt
w0
)2
= 341 kPa×
(1.45
2.31
)2
= 136 kPa (G.2)
The average of the calculated Young’s modulus of all the 6 gels in the sample
with 5 % (w/w) sulfated alginate is given in Table 3.4.1 in Section 3.4, while
the average value for the corrected Young’s modulus is found in Table H.1
in Appendix H.
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H. The Young’s Modulus of
Alginate/Alginate-Sulfate Gels
The Young’s modulus of gels made from alginate DS 0.77/LF200S mixtures
in different proportions were determined by use of a longitudinal compression
test. The initial slope between 0.4 and 0.5 mm in the force- distance plot was
used in the calculations of the Young’s modulus of each sample, according to
Equation 1.4.1.
Because of the syneresis effects of alginate gels, the Young’s modulus for
each sample was corrected for syneresis according to Equation 1.4.2. The
resulting corrected modulus, Ecorr along with the average weight of each gel
sample, the standard deviation and the coefficient of Variation, CoV, of Ecorr
are given in Table H.1, calculated from the initial Young’s modulus given in
Table 3.4.1 in Section 3.4.
As a control for the effect of molecular weight of alginate on gel strength,
gels from three mixtures of hydrolysed alginate (Mw ≈150 kDa) and LF200S
were subjected to the same compression test. The resulting weights of the
gels, the calculated Young’s modulus, the Young’s modulus after correction
for syneresis, and the standard deviation and coefficient of variation of the
corrected E, is given in Table H.2.
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Table H.1: The average weight of the gels from each sample of DS
0.77/LF200S mixtures after syneresis, the corrected Young’s mod-
ulus, Ecorr, the standard deviation and the coefficient of variation,
CoV, for the corrected Young’s modulus.
Amount of
the
Alginate
that is
Sulfated
[%]
Average
Weight of
Gels
Before
Syneresis
[g]
Average
Weight of
Gels After
Syneresis
[g]
Ecorr
[kPa]
The
Standard
Deviation
of Ecorr
[kPa]
CoV
0 2.31 1.53 135 16 0.12
5 2.31 1.44 119 16 0.15
10 2.31 1.36 794 62 0.08
20 2.31 1.39 779 89 0.11
40 2.31 1.36 708 12 0.17
60 2.31 1.46 599 11 0.19
80 2.31 1.68 43 4 0.08
100 2.31 1.81 16 6 0.35
Table H.2: The average weight of the gels from each sample of hy-
drolysed alginate/LF200S mixtures before and after syneresis, the
Young’s modulus, before and after correction for syneresis (E and
Ecorr respectively) the standard deviation and the coefficient of vari-
ation, CoV, for the corrected Young’s modulus.
Amount
Hy-
drolised
Algi-
nate[%]
Average
weight
before
synere-
sis
[g]
Average
Weight
After
Synere-
sis
[g]
The
Young’s
Modu-
lus, E
[kPa]
Ecorr
[kPa]
The
Stan-
dard
Devia-
tion of
Ecorr
[kPa]
CoV
10 2.31 1.49 228 95 13 0.14
20 2.31 1.49 258 106 7 0.07
60 2.31 1.53 251 110 23 0.21
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I. Standard for FGF Using
ELISA and Results from Gel
Disk Mesurements
The release of FGF from alginate/alginate-sulfate gel disks, as well as the re-
maining concentration of FGF in the gel disks after 12 days, were studied by
use of ELISA. A standard curve for FGF concentrations was constructed us-
ing concentrations ranging from 0 to 4000 pg/ml, with the resulting standard
curve and the results for the gel disk measurements given in this appendix.
The standard curve was constructed using the procedure described by the
manufacturer for the ELISA kit, with samples in triplicate. A plate reader
set at 405 nm with 650 nm as the correction wavelength was used to read the
absorbance of the samples. The absorbance read at 650 nm was subtracted
from the one read at 405 nm, giving a net absorbance for all samples. A
second degree polynomial regression line was fitted to the data, with the
constructed standard curve given in Figure I.1.
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Figure I.1: The constructed standard curve for FGF using a sandwich ELISA.
The plate was read with a plate reader set at 405 nm with 650 nm as the
reference wavelength. The net absorbance was found by subtracting the
absorbance read at 650 nm from the one read at 405 nm. A second degree
polynomial regression line was fitted to the data points, and is shown in the
figure.
The remaining concentration of FGF in each gel disks was found using the
procedure described by the manufacturer for the ELISA kit, with samples
in duplicate. A plate reader set at 405 nm with 650 nm as the correction
wavelength was used to read the absorbance of the samples. The absorbance
read at 650 nm was subtracted from the one read at 405 nm, giving a net
absorbance for all samples. The diameter and height of each gel disk were
measured in order to calculate the volume. From the volume, the dilution
factor of each gel disk solution was found using Equation I.1.
Dilution Factor = 10× Vgel + 10.5 ml
Vgel
(I.1)
where Vgel is the volume of the gel disk, 10.5 is the volume the gel disk was
dissolved in, and 10 is the dilution factor for this solution before the ELISA.
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The concentration of FGF in each sample was found by using the average of
the measured absorbances, and the standrad curve from Figure I.1. The con-
centration of FGF in each gel disk was calculated as the product of the con-
centration in the sample and the dilution factor. The measured absorbances,
volumes, dilution factor and FGF concentration of each gel disk are all given
in Table I.1.
Table I.1: The measured absorbances of samples made from dis-
solved gel disks containing FGF after 12 days in a HEPES solution.
A sandwich ELISA was used, and the plates were read using a plate
reader set at 405 nm with 605 nm as a reference wavelength. The
gel diameter and height of each gel disk after 12 days were mea-
sured before the disks were dissolved, and used to calculate the
volume and dilution factor of each gel disk, with results shown in
the table. The concentration of FGF in the samples was calculated
using the average absorbance and the standard curve from Fig-
ure I.1. The concentration in the gel disks were found from these
results and the dilution factor of the gel disks, and can be found
in the table.
Sample 1 2 Average
Volume
of Gel
Disk
[ml]
Dilution
Factor
Concen-
tration
in Plate
Well
[pg/ml]
Concen-
tration
in
Sample
[µg/ml]
0, 1 0.132 0.133 0.132 0.54 204 219 0.04
0, 2 0.214 0.186 0.200 0.69 162 510 0.08
0, 3 0.177 0.178 0.178 0.72 155 406 0.06
20, 1 0.611 0.635 0.623 0.60 185 3623 0.67
20, 2 0.711 0.662 0.686 0.60 185 4286 0.79
20, 3 0.675 0.698 0.686 0.74 151 4285 0.65
40, 1 0.674 0.725 0.699 0.60 186 4428 0.82
40, 2 0.629 0.773 0.701 0.65 170 4447 0.76
40, 3 0.661 0.623 0.642 0.67 166 3817 0.63
60, 1 0.871 0.805 0.838 0.75 150 6077 0.91
60, 2 0.799 0.818 0.809 0.73 154 5707 0.88
60, 3 0.727 0.826 0.777 0.77 146 5315 0.78
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